0001042187 false FY 0001042187 2022-01-01 2022-12-31 0001042187 2022-06-30 0001042187 2023-03-20 0001042187 2021-01-01 2021-12-31 0001042187 2022-12-31 0001042187 2021-12-31 0001042187 us-gaap:SeriesAPreferredStockMember 2022-12-31 0001042187 us-gaap:SeriesAPreferredStockMember 2021-12-31 0001042187 us-gaap:SeriesBPreferredStockMember 2022-12-31 0001042187 us-gaap:SeriesBPreferredStockMember 2021-12-31 0001042187 us-gaap:SeriesCPreferredStockMember 2022-12-31 0001042187 us-gaap:SeriesCPreferredStockMember 2021-12-31 0001042187 us-gaap:SeriesDPreferredStockMember 2022-12-31 0001042187 us-gaap:SeriesDPreferredStockMember 2021-12-31 0001042187 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2020-12-31 0001042187 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2020-12-31 0001042187 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2020-12-31 0001042187 us-gaap:SeriesDPreferredStockMember us-gaap:PreferredStockMember 2020-12-31 0001042187 us-gaap:CommonStockMember 2020-12-31 0001042187 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001042187 us-gaap:RetainedEarningsMember 2020-12-31 0001042187 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001042187 us-gaap:TreasuryStockMember 2020-12-31 0001042187 us-gaap:NoncontrollingInterestMember 2020-12-31 0001042187 2020-12-31 0001042187 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-12-31 0001042187 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2021-12-31 0001042187 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2021-12-31 0001042187 us-gaap:SeriesDPreferredStockMember us-gaap:PreferredStockMember 2021-12-31 0001042187 us-gaap:CommonStockMember 2021-12-31 0001042187 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001042187 us-gaap:RetainedEarningsMember 2021-12-31 0001042187 us-gaap:TreasuryStockMember 2021-12-31 0001042187 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-01-01 2021-12-31 0001042187 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2021-01-01 2021-12-31 0001042187 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2021-01-01 2021-12-31 0001042187 us-gaap:SeriesDPreferredStockMember us-gaap:PreferredStockMember 2021-01-01 2021-12-31 0001042187 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001042187 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001042187 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001042187 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001042187 us-gaap:TreasuryStockMember 2021-01-01 2021-12-31 0001042187 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-12-31 0001042187 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-01-01 2022-12-31 0001042187 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2022-01-01 2022-12-31 0001042187 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2022-01-01 2022-12-31 0001042187 us-gaap:SeriesDPreferredStockMember us-gaap:PreferredStockMember 2022-01-01 2022-12-31 0001042187 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001042187 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001042187 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001042187 us-gaap:TreasuryStockMember 2022-01-01 2022-12-31 0001042187 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001042187 us-gaap:NoncontrollingInterestMember 2021-12-31 0001042187 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001042187 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001042187 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001042187 us-gaap:SeriesDPreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001042187 us-gaap:CommonStockMember 2022-12-31 0001042187 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001042187 us-gaap:RetainedEarningsMember 2022-12-31 0001042187 us-gaap:TreasuryStockMember 2022-12-31 0001042187 srt:MinimumMember us-gaap:BuildingMember 2022-01-01 2022-12-31 0001042187 srt:MaximumMember us-gaap:BuildingMember 2022-01-01 2022-12-31 0001042187 srt:MinimumMember us-gaap:MachineryAndEquipmentMember 2022-01-01 2022-12-31 0001042187 srt:MaximumMember us-gaap:MachineryAndEquipmentMember 2022-01-01 2022-12-31 0001042187 srt:MinimumMember CTIB:ProjectLifeMember 2022-01-01 2022-12-31 0001042187 srt:MaximumMember CTIB:ProjectLifeMember 2022-01-01 2022-12-31 0001042187 srt:MinimumMember CTIB:LightMachineryMember 2022-01-01 2022-12-31 0001042187 srt:MaximumMember CTIB:LightMachineryMember 2022-01-01 2022-12-31 0001042187 srt:MinimumMember CTIB:HeavyEquipmentMember 2022-01-01 2022-12-31 0001042187 srt:MaximumMember CTIB:HeavyEquipmentMember 2022-01-01 2022-12-31 0001042187 srt:MinimumMember us-gaap:FurnitureAndFixturesMember 2022-01-01 2022-12-31 0001042187 srt:MaximumMember us-gaap:FurnitureAndFixturesMember 2022-01-01 2022-12-31 0001042187 srt:MinimumMember us-gaap:IntellectualPropertyMember 2022-01-01 2022-12-31 0001042187 srt:MaximumMember us-gaap:IntellectualPropertyMember 2022-01-01 2022-12-31 0001042187 srt:MinimumMember us-gaap:LeaseholdImprovementsMember 2022-01-01 2022-12-31 0001042187 srt:MaximumMember us-gaap:LeaseholdImprovementsMember 2022-01-01 2022-12-31 0001042187 srt:MinimumMember CTIB:FurnitureAndEquipmentAtCustomerLocationsMember 2022-01-01 2022-12-31 0001042187 srt:MaximumMember CTIB:FurnitureAndEquipmentAtCustomerLocationsMember 2022-01-01 2022-12-31 0001042187 2021-09-01 2022-12-31 0001042187 us-gaap:RevolvingCreditFacilityMember CTIB:PNCAgreementsMember CTIB:PNCMember 2017-12-31 0001042187 CTIB:PNCAgreementsMember CTIB:PNCMember CTIB:TermLoanMember 2017-12-31 0001042187 us-gaap:RevolvingCreditFacilityMember CTIB:LineFinancialAgreementMember CTIB:LineFinancialMember 2021-09-30 0001042187 CTIB:LineFinancialAgreementMember CTIB:LineFinancialMember CTIB:TermLoanMember 2021-09-30 0001042187 us-gaap:SeriesCPreferredStockMember 2021-01-01 2021-01-31 0001042187 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember CTIB:LakeBarringtonFacilityMember 2021-04-23 0001042187 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember CTIB:LakeBarringtonFacilityMember 2021-04-23 2021-04-23 0001042187 CTIB:LoanAgreementMember 2022-01-01 2022-12-31 0001042187 CTIB:LakeBarringtonFacilityLeaseMember 2021-04-23 0001042187 CTIB:UnrelatedThirdPartyMember us-gaap:SeriesDPreferredStockMember 2021-06-01 2021-06-30 0001042187 2022-10-31 0001042187 us-gaap:SubsequentEventMember 2023-01-31 0001042187 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001042187 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember CTIB:CustomerOneMember 2022-01-01 2022-12-31 0001042187 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember CTIB:CustomerTwoMember 2022-01-01 2022-12-31 0001042187 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001042187 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember CTIB:CustomerOneMember 2021-01-01 2021-12-31 0001042187 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember CTIB:CustomerTwoMember 2021-01-01 2021-12-31 0001042187 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember CTIB:CustomerOneMember 2022-12-31 0001042187 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember CTIB:CustomerTwoMember 2021-12-31 0001042187 us-gaap:SubordinatedDebtMember srt:OfficerMember 2022-12-31 0001042187 us-gaap:SubordinatedDebtMember srt:OfficerMember 2021-12-31 0001042187 CTIB:NotesPayableRelatedPartyMember 2022-12-31 0001042187 CTIB:NotesPayableRelatedPartyMember 2021-12-31 0001042187 CTIB:TermLoanMember 2022-12-31 0001042187 CTIB:TermLoanMember 2021-12-31 0001042187 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2022-12-31 0001042187 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2021-12-31 0001042187 CTIB:LineFinancialAgreementMember us-gaap:PrimeRateMember 2022-12-16 0001042187 CTIB:LineFinancialAgreementMember us-gaap:PrimeRateMember 2022-12-16 2022-12-16 0001042187 CTIB:LineFinancialAgreementMember 2022-12-16 0001042187 CTIB:LineFinancialAgreementMember 2021-11-01 2021-11-01 0001042187 CTIB:LineFinancialAgreementMember 2021-09-30 0001042187 CTIB:LineFinancialAgreementMember 2022-08-31 0001042187 2021-09-01 2021-09-30 0001042187 2021-09-30 0001042187 CTIB:LineFinancialAgreementMember 2021-12-31 2021-12-31 0001042187 CTIB:LineFinancialAgreementMember srt:MaximumMember 2022-01-01 2022-12-31 0001042187 us-gaap:RevolvingCreditFacilityMember 2022-12-31 0001042187 us-gaap:RevolvingCreditFacilityMember 2021-12-31 0001042187 CTIB:JohnHSchwanMember 2019-01-01 0001042187 CTIB:JohnHSchwanMember 2019-01-01 2019-01-31 0001042187 us-gaap:CommonStockMember CTIB:JohnHSchwanMember 2019-01-31 0001042187 CTIB:JohnHSchwanMember 2022-12-31 0001042187 CTIB:JohnHSchwanMember 2021-12-31 0001042187 CTIB:JohnHSchwanMember 2022-01-01 2022-12-31 0001042187 CTIB:JohnHSchwanMember 2021-01-01 2021-12-31 0001042187 CTIB:PromissoryNoteMember CTIB:JohnHSchwanMember 2022-10-01 2022-12-31 0001042187 CTIB:PromissoryNoteMember CTIB:JohnHSchwanMember 2021-10-01 2021-12-31 0001042187 CTIB:PromissoryNoteMember CTIB:JohnHSchwanMember 2022-01-01 2022-12-31 0001042187 CTIB:PromissoryNoteMember CTIB:JohnHSchwanMember 2021-01-01 2021-12-31 0001042187 CTIB:AlexFengMember 2021-12-31 0001042187 CTIB:AlexFengMember 2021-01-01 2021-12-31 0001042187 2017-12-21 2017-12-22 0001042187 us-gaap:DomesticCountryMember us-gaap:InternalRevenueServiceIRSMember 2022-12-31 0001042187 us-gaap:StateAndLocalJurisdictionMember 2022-12-31 0001042187 CTIB:SchwanIncorporatedMember 2022-01-01 2022-12-31 0001042187 CTIB:SchwanIncorporatedMember 2021-01-01 2021-12-31 0001042187 us-gaap:AccountingStandardsUpdate201602Member 2022-12-31 0001042187 CTIB:StockPurchaseAgreementMember us-gaap:SeriesAPreferredStockMember 2020-01-02 2020-01-03 0001042187 CTIB:StockPurchaseAgreementMember us-gaap:SeriesAPreferredStockMember 2020-01-03 0001042187 us-gaap:SeriesAPreferredStockMember CTIB:AdditionalSharesOfferingMember 2020-01-02 2020-01-03 0001042187 us-gaap:SeriesAPreferredStockMember us-gaap:InvestorMember 2020-01-02 2020-01-03 0001042187 us-gaap:CommonStockMember CTIB:LFInternationalOfferingMember 2020-01-02 2020-01-03 0001042187 us-gaap:SeriesAPreferredStockMember 2020-01-02 2020-01-03 0001042187 us-gaap:SeriesAPreferredStockMember 2020-01-03 0001042187 us-gaap:SeriesAPreferredStockMember 2022-07-01 2022-09-30 0001042187 us-gaap:SeriesAPreferredStockMember 2022-01-01 2022-09-30 0001042187 us-gaap:CommonStockMember CTIB:ConvertibleSeriesAPreferredStockMember 2022-09-01 0001042187 us-gaap:CommonStockMember CTIB:ConvertibleSeriesAPreferredStockMember 2022-09-01 2022-09-01 0001042187 us-gaap:SeriesBPreferredStockMember 2020-11-01 2020-11-30 0001042187 us-gaap:SeriesBPreferredStockMember 2020-11-30 0001042187 us-gaap:SeriesBPreferredStockMember 2022-01-01 2022-12-31 0001042187 us-gaap:CommonStockMember CTIB:ConvertibleSeriesCPreferredStockMember us-gaap:SubsequentEventMember 2023-02-01 0001042187 us-gaap:SeriesCPreferredStockMember 2021-01-31 0001042187 us-gaap:CommonStockMember CTIB:ConvertibleSeriesCPreferredStockMember 2022-09-01 0001042187 us-gaap:CommonStockMember CTIB:ConvertibleSeriesCPreferredStockMember 2022-09-01 2022-09-01 0001042187 CTIB:UnrelatedThirdPartyMember us-gaap:SeriesDPreferredStockMember 2021-06-01 2021-06-30 0001042187 us-gaap:SeriesDPreferredStockMember 2021-09-29 2021-09-30 0001042187 us-gaap:SeriesDPreferredStockMember 2021-12-30 2021-12-31 0001042187 us-gaap:SeriesDPreferredStockMember 2021-01-01 2021-12-31 0001042187 us-gaap:SeriesDPreferredStockMember 2022-09-01 0001042187 us-gaap:CommonStockMember CTIB:ConvertibleSeriesDPreferredStockMember 2022-09-01 0001042187 us-gaap:CommonStockMember CTIB:ConvertibleSeriesDPreferredStockMember 2022-09-01 2022-09-01 0001042187 us-gaap:WarrantMember 2021-12-31 0001042187 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001042187 us-gaap:WarrantMember 2022-12-31 0001042187 CTIB:TwoThousandAndTwentyOneWarrantsMember 2021-12-31 0001042187 CTIB:TwoThousandAndTwentyOneWarrantsMember 2022-12-31 0001042187 CTIB:LFInternationalPteMember 2020-01-01 2020-12-31 0001042187 CTIB:GardenStateSecuritiesMember 2020-01-01 2020-12-31 0001042187 us-gaap:RestrictedStockMember CTIB:MrHylandMember 2020-01-01 2020-12-31 0001042187 us-gaap:RestrictedStockMember 2021-12-31 0001042187 us-gaap:RestrictedStockMember 2020-12-31 0001042187 us-gaap:RestrictedStockMember srt:ChiefExecutiveOfficerMember 2022-01-01 2022-12-31 0001042187 us-gaap:RestrictedStockMember srt:DirectorMember 2022-01-01 2022-12-31 0001042187 us-gaap:RestrictedStockMember srt:ChiefOperatingOfficerMember 2022-01-01 2022-12-31 0001042187 us-gaap:RestrictedStockMember srt:ChiefOperatingOfficerMember 2022-12-31 0001042187 us-gaap:RestrictedStockMember srt:ChiefExecutiveOfficerMember 2022-12-31 0001042187 CTIB:StockIncentivePlan2009Member 2009-04-10 0001042187 CTIB:StockIncentivePlan2018Member 2018-06-08 0001042187 CTIB:StockIncentivePlan2018Member 2022-06-17 0001042187 us-gaap:PerformanceSharesMember 2022-01-01 2022-12-31 0001042187 CTIB:SeriesAWarrantMember 2020-01-01 2020-12-31 0001042187 CTIB:SeriesAWarrantMember 2020-12-31 0001042187 CTIB:SeriesAWarrantMember 2021-02-01 2021-02-28 0001042187 CTIB:SeriesAPreferredStockWarrantsMember 2022-01-01 2022-12-31 0001042187 CTIB:SeriesAWarrantMember 2022-12-31 0001042187 us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-12-31 0001042187 us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-12-31 0001042187 us-gaap:MeasurementInputExpectedTermMember 2022-12-31 0001042187 us-gaap:MeasurementInputExpectedTermMember 2021-12-31 0001042187 us-gaap:MeasurementInputExpectedDividendRateMember 2022-12-31 0001042187 us-gaap:MeasurementInputExpectedDividendRateMember 2021-12-31 0001042187 CTIB:FoilBalloonsMember 2022-01-01 2022-12-31 0001042187 CTIB:FoilBalloonsMember 2021-01-01 2021-12-31 0001042187 CTIB:FilmProductsMember 2022-01-01 2022-12-31 0001042187 CTIB:FilmProductsMember 2021-01-01 2021-12-31 0001042187 CTIB:OtherProductsMember 2022-01-01 2022-12-31 0001042187 CTIB:OtherProductsMember 2021-01-01 2021-12-31 0001042187 CTIB:CTIEuropeMember 2019-12-31 0001042187 CTIB:CtiBalloonsAndCtiEuropeMember 2019-12-31 0001042187 CTIB:ZiplocProductLineMember us-gaap:SegmentDiscontinuedOperationsMember 2020-01-01 2020-12-31 0001042187 CTIB:ZiplocProductLineMember us-gaap:SegmentDiscontinuedOperationsMember 2019-01-01 2019-12-31 0001042187 CTIB:FlexoUniversalMember us-gaap:SegmentDiscontinuedOperationsMember 2021-10-01 2021-12-31 0001042187 us-gaap:SegmentDiscontinuedOperationsMember CTIB:FlexoUniversalMember 2021-01-01 2021-12-31 0001042187 CTIB:FlexoUniversalMember us-gaap:SegmentDiscontinuedOperationsMember 2021-12-31 0001042187 2022-05-01 2022-05-31 0001042187 us-gaap:SeriesBPreferredStockMember us-gaap:SubsequentEventMember 2023-02-01 2023-02-28 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure CTIB:Integer CTIB:Customers

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

 

FORM 10-K

 

(Mark One)

☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended December 31, 2022

 

OR

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _________to_________

 

Commission File Number

000-23115

 

YUNHONG CTI LTD.

(Exact name of registrant as specified in its charter)

 

Illinois   36-2848943
(State or other jurisdiction of   (I.R.S. Employer
incorporation or organization)   Identification No.)
     
22160 N. Pepper Road    
Lake Barrington, Illinois   60010
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (847) 382-1000

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Ticker symbol(s)  

Name of each exchange on which registered

Common Stock, no par value per share   CTIB   The NASDAQ Stock Market LLC

 

Securities registered pursuant to Section 12(g) of the Act: None

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act. Yes ☐ No ☒

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☒ Smaller Reporting Company ☒ Emerging Growth Company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant has fi led a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting fi rm that prepared or issued its audit report. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

 

Based upon the closing price of $0.71 per share of the Registrant’s Common Stock as reported on NASDAQ Capital Market tier of The NASDAQ Stock Market on June 30, 2022, the aggregate market value of the voting common stock held by non-affiliates of the Registrant was then approximately $3,912,000. (The determination of stock ownership by non-affiliates was made solely for the purpose of responding to the requirements of the Form and the Registrant is not bound by this determination for any other purpose.)

 

The number of shares outstanding of the Registrant’s Common Stock as of March 20, 2023 was 19,971,755 (excluding treasury shares).

 

DOCUMENTS INCORPORATED BY REFERENCE

 

The Registrant’s definitive Proxy Statement for the Annual Meeting of Stockholders (the “2023 Proxy Statement”) is incorporated by reference in Part III of this Form 10-K to the extent stated herein. The 2023 Proxy Statement, or an amendment to this Form 10-K, will be filed with the SEC within 120 days after December 31, 2022. Except with respect to information specifically incorporated by reference in this Form 10-K, the Proxy Statement is not deemed to be filed as a part hereof.

 

 

 

   

 

 

TABLE OF CONTENTS

 

INDEX

 

FORWARD LOOKING STATEMENTS

 

Part I    
     
Item No. 1 Description of Business 1
Item No. 1B Unresolved Staff Comments 10
Item No. 2 Properties 10
Item No. 3 Legal Proceedings 10
     
Part II    
     
Item No. 5 Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 10
Item No. 7 Management’s Discussion and Analysis of Financial Condition and Results of Operations 11
Item No. 7A Quantitative and Qualitative Disclosures Regarding Market Risk 20
Item No. 8 Financial Statements and Supplementary Data 20
Item No. 9 Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 20
Item No. 9A Controls and Procedures 20
Item No. 9B Other Information 21
     
Part III    
     
Item No. 10 Directors and Executive Officers of the Registrant 21
Item No. 11 Executive Compensation 26
Item No. 12 Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 29
Item No. 13 Certain Relationships and Related Transactions 31
Item No. 14 Principal Accounting Fees and Services 31
     
Part IV    
     
Item No. 15 Exhibits and Financial Statement Schedules 32

 

 

 

FORWARD-LOOKING STATEMENTS

 

This Annual Report on Form 10-K includes both historical and “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. We have based these forward-looking statements on our current expectations and projections about future results. Words such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” or similar words are intended to identify forward-looking statements, although not all forward-looking statements contain these words. Although we believe that our opinions and expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements, and our actual results may differ substantially from the views and expectations set forth in this Annual Report on Form 10-K. We disclaim any intent or obligation to update any forward-looking statements after the date of this Annual Report on Form 10-K to conform such statements to actual results or to changes in our opinions or expectations. These forward-looking statements are affected by factors, risks, uncertainties and assumptions that we make, including, without limitation, our participation in highly competitive markets, potential changes in the cost or availability of raw materials, our dependence on a limited number of suppliers, the possible inability to obtain an adequate supply of raw materials, our reliance on a limited number of key customers, the loss of one or more of our key customers, changing consumer demands, developments or changes in technology, risks of international operations and political environments, dependence on our intellectual property, compliance with federal, state or local regulations, the resolution of litigation or other legal proceedings to which we may become involved, restrictions included in the Company’s credit facility, the availability of funds under the Company’s credit facility, damage to or destruction of one or both of the Company’s principal plants, our ability to service our indebtedness, our ability to invest in needed plant or equipment.

 

PART I

 

Item No. 1 –Business

 

Business Overview

 

We develop, produce, distribute and sell a number of consumer products throughout the United States and in several other countries, and we produce film products for commercial and industrial uses in the United States. Many of our products utilize flexible films and, for a number of years, we have been a leading developer of innovative products which employ flexible films including novelty balloons, pouches and films for commercial packaging applications.

 

Our principal lines of products include:

 

Novelty Products consisting principally of foil and latex balloons and related gift items; and

 

Flexible Films for food and other commercial and packaging applications.

 

In addition to these principal product lines, for the past several years, we have engaged in the assembly and sale of Candy Blossoms (small gift bouquets of arranged candy items often including ribbons and/or a small foil balloon).

 

We leverage our technology to design and develop proprietary products which we develop, market and sell for our customers. We have been engaged in the business of developing flexible film products for over 40 years and have acquired significant technology and know-how in that time. We currently hold several patents related to flexible film products, including specific films, zipper closures, valves and other features of these products.

 

1

 

We print, process and convert flexible film into finished products and we produce balloons and novelty items. Our principal production processes include:

 

  ● Coating and laminating rolls of flexible film. Generally, we adhere polyethylene film to another film such as nylon or polyester;

 

  ● Printing film and latex balloons. We print on plastic films, with a variety of graphics, for use as packaging film or for balloons;

 

  ● Converting printed film to balloons;

 

  ● Converting film to flexible containers;

 

  ● Producing or reselling latex balloons and other latex novelty items; and

 

  ● Assembling and inflating of novelty products and balloons and Candy Blossoms.

 

In 1978, we began manufacturing metalized balloons (often referred to as “foil” balloons), which are balloons made of a base material (usually nylon or polyester) often having vacuum deposited aluminum and polyethylene coatings. These balloons remain buoyant when filled with helium for much longer periods than latex balloons and permit the printing of graphic designs on the surface. In 1985, we began marketing latex balloons and, in 1988, we began manufacturing latex balloons. In 1999, we acquired an extrusion coating and laminating machine and began production of coated and laminated films, which we have produced since that time.

 

For more than 20 years, we have been engaged in the coating, laminating and printing of flexible films for our novelty and container products and for the production of laminated and printed films we supply to others.

 

We market and sell our foil and latex balloons and related novelty items throughout the United States, Canada and Mexico and in a number of other countries. We supply directly to retail stores and chains and through distributors, who in turn sell to retail stores and chains. Our balloon and novelty products are sold to consumers through a wide variety of retail outlets including general merchandise, discount and drugstore chains, grocery chains, card and gift shops and party goods stores, as well as through florists and balloon decorators.

 

Most of our foil balloons contain printed characters, designs and social expression messages, such as “Happy Birthday,” “Get Well” and similar items. We may obtain licenses from time to time for well-known characters and print those characters and messages on our balloons.

 

We provide customized laminated films and printed films to customers who utilize the film to produce bags or pouches for the packaging of food, liquids and other items. In 2014, we began assembling and producing Candy Blossoms - containers including candy items and, often, air-inflated balloons.

 

In 2022, our revenues from our product lines, as a percent of total revenues were:

 

● Novelty Products 60% of revenues
● Flexible Film Products 11% of revenues
● Candy Blossoms and Other Products 29% of revenues

 

We are an Illinois corporation with our principal offices and plant at 22160 N. Pepper Road, Lake Barrington, Illinois.

 

2

 

Business Strategies and Developments

 

Our business strategies, and recent developments related to our business, include:

 

  ● Management. During December 2019, Mr. Frank Cesario, who joined CTI during 2017 as Chief Financial Officer, became both President and Chief Executive Officer. During 2020 we changed our name to Yunhong CTI Ltd., as we received a significant investment from LF International Pte, Ltd. Mr. Yubao Li, Chairman of the Yunhong China Group, became a director and then Chairman of Yunhong CTI Ltd. He replaced Mr. Cesario in September 2020 as Chief Executive Officer, at which time Mr. Cesario retired from the Company. During 2020 Ms. Jana Schwan became our Chief Operating Officer after having served as Vice President of Operations and a number of other roles of increasing responsibility during her 20 years with the Company. During 2021, Mr. Cesario rejoined the Company’s Board of Directors. During January 2022, Mr. Cesario rejoined the Company as Chief Executive Officer, with Mr. Li retaining the role of Chairman of the Board of Directors.

 

  ● Financing. From 2018 through 2020 we had multiple events of default with our primary lender, resulting in the Company incurring substantial penalties and fees. In addition, the Company had to enter into several forbearance agreements, pursuant to which the lender agreed to not take action against the Company for its default. During 2020 we entered into several individual securities purchase agreements with certain accredited investors for the purchase of shares of our Series A and B Convertible Preferred Stock. We sold Series C and D Convertible Preferred Stock during 2021 and executed a sale / leaseback transaction of our Lake Barrington, IL property. We entered into a smaller credit facility with a new entity during September 2021 as we repaid our prior lender and terminated that prior credit facility. We have remained in compliance with this credit facility since inception (September 2021).

 

  ● Strategy. Our management determined to focus on achieving growth and profitability within the current scope of our core product lines – foil balloons and related products – from our United States based business. We reviewed our operations and, during 2019, decided to sell or liquidate our subsidiaries in the UK and Europe. We attempted to sell our subsidiary in Mexico in early 2020, which was not successful at the time (during to the Covid-19 pandemic). That effort was ultimately completed during October 2021. In an attempt to increase profitability, we announced an intention to relocate our warehousing and light assembly facility from Lake Zurich, IL to Laredo, TX during 2020. Due to certain factors including the Covid-19 pandemic, we instead relocated this facility to Elgin, IL during March 2021 and are no longer pursuing a relocation to Texas.

 

  ● Focus on our Core Assets and Expertise. We have been engaged in the development, production and sale of film and container products for 40 years and have developed assets, technology and expertise which, we believe, enable us to develop, manufacture, purchase, market and sell innovative products of high quality within our areas of knowledge and expertise. We have focused our efforts on these core assets and areas of expertise – film novelty products, specialty film products, laminated films and printed films – to develop new products, to market and sell our products and to build our revenues.

 

  ● Develop New Products, Product Improvements and Technologies. We engage in research, design, innovation and development for the purpose of developing and improving products, materials, methods and technologies within our core product categories. We work to develop and identify new products, to improve existing products and to develop new technologies within our core product areas in order to enhance our competitive position and increase our sales. We seek to leverage our technology to develop innovative and proprietary products. In our novelty product lines, our development work includes new designs, new character licenses, new product developments, new materials and improved production methods. We work with customers to develop custom film products which serve the unique needs or requirements of the customer. Now that we are connected to the Yunhong China Group, we plan to look for additional opportunities to add value and grow with group members.

 

  ● Develop New Channels of Distribution and New Sales Relationships. We seek to organically develop new channels of distribution and new sales relationships, both for existing and new products. Over the past several years, we have developed new distributors and customers for our products in the United States and in Europe, Mexico, Latin America and Australia. We also look to leverage resources within the Yunhong China Group for a wide range of topics, from sales to sourcing.

 

  ● Product and Line Extensions. We intend to pursue new product lines and product line extensions, through internal developments.

 

3

 

Products

 

Foil Balloons. We have designed, produced and sold foil balloons since 1979 and, we believe, are one of the larger manufacturers of foil balloons in the United States. Currently, we produce several hundred foil balloon designs, in different shapes and sizes.

 

In addition to size and shape, a principal element of our foil balloon products is the printed design or message contained on the balloon. These designs may include figures and licensed characters, but typically are of our own design. We recognize that consumer trends and preferences, and competing products, are constantly changing. In order to compete effectively in this product line we must constantly innovate and develop new designs, shapes and products.

 

Latex Balloons. Our former subsidiary in Guadalajara, Mexico, Flexo Universal, S. de R.L. de C.V. (“Flexo Universal”) manufactures latex balloons in a wide variety of sizes and colors. Flexo Universal was sold during October 2021. The Company currently sources latex products from a foreign supplier and resells those products to customers that seek both foil and latex solutions.

 

Packaging Films and Custom Film Products. A large and increasing number of both consumer and commercial products are packaged in pouches or containers utilizing flexible films. Often such containers include printed labels and designs. We produce and sell films that may be utilized for the packaging of a wide variety of products and liquids. We laminate, extrusion coat and adhesive coat flexible films for these purposes and we provide flexographic printing for the films we produce. We can produce a variety of customized film products, and printing services, to meet the specific packaging needs of a wide variety of customers.

 

Other Products. In 2014, we began assembly and sale of our Candy Blossom product line (typically a presentation of candy with a balloon in a decorate arrangement for gifting). We have since supplemented this product line with related products.

 

Markets

 

Foil Balloons

 

The foil balloon came into existence in the late 1970s. During the 1980s, the market for foil balloons grew rapidly. Initially, the product was sold principally to individual vendors, small retail outlets and at fairs, amusement parks, shopping centers and other outdoor facilities and functions. Foil balloons remain buoyant when filled with helium for extended periods of time and they permit the printing and display of graphics and messages. As a result, the product has significant appeal as a novelty and message item. Foil balloons became part of the “social expression” industry, carrying graphics designs, characters and messages like greeting cards. In the mid-1980s, we and other participants in the market began licensing character and cartoon images for printing on the balloons and directed marketing of the balloons to retail outlets including grocery, general merchandise, discount and drug store chains, card and gift shops, party goods stores as well as florists and balloon decorators. These outlets now represent the principal means for the sale of foil balloons throughout the United States and in a number of other countries, although individual vendors remain a means of distribution in certain areas.

 

Foil balloons are now sold in virtually every region of the world. The United States remains the largest market for these products.

 

Foil balloons are sold in the United States and foreign countries directly by producers to retail outlets and through distributors and wholesalers. Often the sale of foil balloons by the wholesalers/distributors is accompanied by related products including latex balloons, floral supplies, candy containers, mugs, plush toys, baskets and a variety of party goods.

 

4

 

Latex Balloons

 

For a number of years, latex balloons and related novelty/toy latex items have been marketed and sold throughout the United States and in many other countries. Latex balloons are sold as novelty/toy items for decorative purposes, as part of floral designs and as party goods and favors. In addition to standard size and shape balloons, inflatable latex items include punch balls, water bombs, balloons to be twisted into shapes, and other specialty designs. Often, latex balloons include printed messages or designs.

 

Latex balloons are sold principally in retail outlets, including party goods stores, general merchandise stores, discount chains, gift stores and drugstore chains. Latex balloons are also purchased by balloon decorators and floral outlets for use in decorative or floral designs. Printed latex balloons are sold both in retail outlets and for balloon decoration purposes including floral designs.

 

Latex balloons are sold both through distributors and directly to retail outlets by the producers.

 

Printed and Specialty Films

 

The industry and market for printed and specialty films are fragmented and include many participants. There are hundreds of manufacturers of printed and specialty film products in the United States and in other markets. In many cases, companies who provide food and other products in film packages also produce or process the films used for their packages. The market for the Company’s film products consists principally of companies who utilize the films for the packaging of their products, including food products and other items, usually by converting the film to a flexible container.

 

Marketing, Sales and Distribution

 

Balloon Products

 

We work in collaboration with our customers on designs, promotions, and other elements of marketing and selling. Our customers are typically retailers who sell our products to individual consumers. These relationships generally can be terminated unilaterally by either us or our customers. We must maintain good relationships with our customers if this sales model is to be successful.

 

We market and sell our foil balloon, latex balloon and related novelty products throughout the United States and in a number of other countries. We maintain marketing, sales and support staff and a customer service department in the United States. We sell directly to foreign customers from the United States.

 

We sell and distribute our balloon products (i) through our sales staff and customer service personnel in the United States, (ii) through a network of distributors and wholesalers, (iii) through several groups of independent sales representatives, and (iv) to retail chains. Our balloon products are generally sold through retail outlets including grocery, general merchandise and drug store chains, card and gift shops, party goods stores as well as florists and balloon decorators.

 

We sometimes engage in advertising and promotional activities to promote the sale of our balloon products. We produce catalogs of our balloon products, and also prepare various flyers and brochures for special or seasonal products, which we disseminate to customers, potential customers and others. We maintain websites which show images of our products.

 

Printed and Specialty Films

 

We market and sell printed and laminated films directly and through independent sales representatives throughout the United States. We sell laminated and printed films to companies that utilize these films to produce packaging for a variety of products, including food products, in both solid and liquid form, such as cola syrup, coffee, juices and other items. We seek to identify and maintain customer relationships in which we provide added value in the form of technology or systems.

 

Other Products

 

Other products are sold by our internal sales force directly to customers and also by independent sales representatives. These products are generally sold directly to retail outlets or other intermediaries to the ultimate consumer (for example, to a florist).

 

5

 

Production and Operations

 

We conduct our operations at our facilities including: (i) our 68,000 square feet facility in Lake Barrington, Illinois, incorporating our headquarters office, production and warehouse space, and (ii) our 69,000 square foot facility in Elgin, Illinois consisting of warehouse, packaging and office space.

 

Our production operations include (i) lamination and extrusion coating of films, (ii) slitting of film rolls, (iii) printing on film and on latex balloons, (iv) converting film to completed products including balloons, flexible containers and pouches, (v) distributing latex balloon products, (vi) inflating of air-filled balloons, and (vii) assembling Candy blossoms. We perform all of the lamination, extrusion coating and slitting activities in our Lake Barrington, Illinois plant. We complete air-filling and assembly of balloons and Candy Blossoms in our Elgin, Illinois facility.

 

We warehouse raw materials in Lake Barrington, Illinois and we warehouse finished goods at our facilities in Lake Barrington, Illinois and Elgin, Illinois. We maintain customer service and fulfillment operations at each of our locations. We conduct sales operations for the United States and for all other markets at the Lake Barrington, Illinois facility.

 

We maintain a graphic arts and development department at our Lake Barrington, Illinois facility which designs our balloon products and graphics. Our creative department operates a networked, computerized graphic arts system for the production of these designs and of printed materials including catalogues, advertisements and other promotional materials. As many of our products are custom designed or created to fulfill promotional schedules, we sometimes have excess inventory that must be sold at a discount or disposed of. Any such disposition will typically negatively impact our profit margin.

 

We conduct administrative and accounting functions at our headquarters in Lake Barrington, Illinois.

 

Raw Materials

 

The principal raw materials we use in manufacturing our products are (i) petroleum or natural gas-based films, (ii) petroleum or natural gas-based resin, (iii) printing inks, and (iv) bulk candy. The cost of raw materials represents a significant portion of the total cost of our products, with the result that fluctuations in the cost of raw materials have a material effect on our profitability. During the past several years, we have experienced significant fluctuations in the cost of these raw materials. We do not have any long-term agreements for the supply of raw materials and may experience wide fluctuations in the cost of raw materials in the future. Further, although we have been able to obtain adequate supplies of raw materials in the past, there can be no assurance that we will be able to obtain adequate supplies of one or more of our raw materials in the future.

 

Many of the foil balloons we produce and sell are intended to be filled with helium in order to be buoyant. Over the past several years, the price of helium has fluctuated substantially and the availability of helium has, on occasion, been limited. During 2018 and 2019, the availability of helium declined and the cost of helium increased. The supply of helium improved significantly until 2022, when another set of supply disruptions caused significant price escalation of helium. The price of helium has gradually decreased during the second half of 2022 and into 2023, but remains higher than prior to February 2022. Any future occurrence of limited availability and/or an increase in the cost of helium could adversely affect our sales of foil balloons.

 

6

 

Competition

 

The balloon and novelty industry is highly competitive, with numerous competitors. We believe the principal manufacturers of foil balloons whose products are sold in the United States include Anagram International, Inc., Pioneer Balloon Company, Convertidora International S.A. de C.V., and Betallic, LLC. Several companies market and sell foil balloons designed by them and manufactured by others for them. In addition, there are several additional foil balloon manufacturers in Europe and China who participate in our markets.

 

We compete for the sale of latex balloons in the United States, Canada, Mexico, Latin America, the United Kingdom, Australia and Europe. There are a number of other companies situated in the United States, Mexico, Asia, South America and Europe who manufacture latex balloons and with whom we compete in the markets in which we participate. The markets are highly competitive with respect to price, quality and terms.

 

The market for films, packaging, and custom products is fragmented, and competition in this area is difficult to gauge. However, there are numerous participants in this market and the Company can expect to experience intense quality and price competition.

 

Many of the companies in these markets offer products and services that are the same or similar to those offered by us and our ability to compete depends on many factors within and outside our control. There are a number of well-established competitors in each of our product lines, several of which possess substantially greater financial, marketing and technical resources and have established extensive, direct and indirect channels of distribution for their products and services. As a result, such competitors may be able to respond more quickly to new developments and changes in customer requirements, or devote greater resources to the development, promotion and sale of their products and services than we can. Competitive pressures include, among other things, price competition, new designs and product development and copyright licensing.

 

Patents, Trademarks and Copyrights

 

We have developed or acquired a number of intellectual property rights which we believe are significant to our business. As of December 31, 2022, we held 1 issued patent in the United States scheduled to expire in 2024. While intellectual property rights are helpful, we believe that their degree of protection is uncertain. Competitors may violate our intellectual property rights, forcing us to decide whether to challenge them. Such rights may or may not withstand challenge. Conversely, entities may charge us with violating their intellectual property rights. Failure to protect our rights, or conflict with the rights of one or more other entities, may negatively impact our financial and competitive position.

 

Proprietary Designs and Copyright Licenses. We design the shapes and graphic designs of most of our foil balloon products.

 

Trademarks. We own nine registered trademarks in the United States relating to our balloon products, including trademark applications. Some of these trademarks are registered in foreign countries, principally in the European Union.

 

Patent Rights. We own, or have license rights under, or have applied for, patents related to our balloon products, certain film products and certain flexible container products.

 

Research and Development

 

We maintain a product development and research group for the development or identification of new products, product designs, product components and sources of supply. Research and development includes (i) creative product development and design, (ii) creative marketing, and (iii) engineering development. During each of the fiscal years ended December 31, 2022 and 2021, we estimate that the total amount spent on research and development activities was approximately $200,000 and $206,000, respectively.

 

7

 

Employees

 

As of December 31, 2022, the Company had 58 full-time employees in the United States, of whom 14 are executive or supervisory, 2 are in sales, 29 are in manufacturing or warehouse functions and 13 are clerical. The Company is not a party to any collective bargaining agreement in the United States, has not experienced any work stoppages, and believes that its relationship with its employees is satisfactory.

 

Beginning November 2018, the Company experienced severe difficulty in securing adequate seasonal workers in its US operations, forcing it to pay substantially higher costs in the form of overtime and a holiday premium. The Company expects its local labor market in the US (near Chicago) to continue to become more costly over time, which, if not changed, would negatively impact its future profitability. The Company has introduced additional automation features in its production lines during 2022 and expects to continue to implement automation tools during 2023 and beyond.

 

Regulatory Matters

 

Our manufacturing operations in the United States are subject to the U.S. Occupational Safety and Health Act (“OSHA”). We believe we are in material compliance with OSHA. The Company generates liquid, gaseous and solid waste materials in its operations in Lake Barrington, Illinois and the generation, emission or disposal of such waste materials are, or may be, subject to various federal, state and local laws and regulations regarding the generation, emission or disposal of waste materials. We believe we are in material compliance with applicable environmental rules and regulations. Several states have enacted laws limiting or restricting the release of helium filled foil balloons. We do not believe such legislation will have any material effect on our operations.

 

An increasing number of regulations and actions relate to the integrity and security of individually identifiable data. Additionally, we require the effective use of data in running our business. While we are not aware of losses in the past, access of such data by unauthorized persons may expose us to costs, fines, penalties, and loss of customer confidence.

 

International Operations

 

We conducted operations in one location outside of the United States as recently as October 2021 when we sold our Flexo Universal manufacturing operation (a latex balloon manufacturer based in Guadalajara, Mexico). Today we have no international operations.

 

Available Information

 

We maintain our corporate website at www.ctiindustries.com and we make available, free of charge, through this website our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to those reports that we file with, or furnish to, the Securities and Exchange Commission (“SEC”), as soon as reasonably practicable after we electronically file that material with, or furnish it to, the SEC. You may also read and copy material filed by us with the SEC at the SEC’s Public Reference Room at 100 F Street, N.E., Washington, D.C. 20549, and you may obtain information on the operation of the Public Reference Room by calling the SEC in the U.S. at 1-800-SEC-0330. In addition, the SEC maintains an Internet website, www.sec.gov, which contains reports, proxy and information statements and other information that we file electronically with the SEC. Our website also includes corporate governance information, including our Code of Ethics and our Board Committee Charters. The information contained on our website does not constitute a part of this report.

 

8

 

Item No. 1A – Risk Factors

 

Our business and results of operations have been and may continue to be negatively impacted by the spread of COVID-19.

 

We sell our products throughout the United States and in many foreign countries and may be impacted by public health crises beyond our control. This could disrupt our operations and negatively impact consumer spending and confidence levels, and supply availability and costs, all of which can affect our financial results, condition, and outlook. Our customers, suppliers and distributors may experience similar disruption. Importantly, the global pandemic resulting from COVID-19 has disrupted global health, economic and market conditions.

 

Throughout 2021 and into 2022 the landscape improved from 2020, but the issue continues to drive elements of disruption in the ability to travel, attract and retain workers, manage production configurations and protocols, the supply chain and customer base. While we cannot predict the duration or scope of the COVID-19 pandemic, the resurgence of infections in one or more markets, or the impact of vaccines across the globe, the COVID-19 pandemic has negatively impacted our business and is expected to continue to impact our financial results, condition and outlook in a way that may be material.

 

COVID-19 has also delayed certain strategic transactions the Company intended to close during 2020, most notably its attempted sale of Flexo Universal which was ultimately realized during October 2021 and the potential relocation of certain activities to the Laredo, Texas area, which is no longer a consideration of the Company.

 

Our business and results of operations have been and may continue to be negatively impacted by supply chain disruptions and inflationary pressure.

 

Beginning in 2021 we saw material shortages, supply chain interruption, and reduced ability to transport goods throughout the United States and on a global scale. These pressures forced us to take steps to ensure the availability of products, including buying materials at higher prices and more aggressively managing lead times. Despite these efforts, our ability to fulfill customer demands was challenged. We also were forced to pass cost increases on to customers in the form of price increases, which threatened our ability to maintain sales volume. While we believe we were largely successful in passing along these increased costs, such pressures may negatively impact our financial results and book of business going forward.

 

The price and availability of helium may negatively impact our largest product line.

 

Beginning in February 2022 we saw a dramatic increase in the price of helium. We understand Russia to be a net exporter of helium prior to February 2022, and one of the largest manufacturing facilities in the United States was damaged by fire. Our largest product line consists of balloons that are filled with helium by customers. When the cost of helium increases, our customers become more likely to temporarily not carry helium, or to increase prices to customers that may have a negative impact on ultimate demand. From May 2022 through the end of 2022, we believe our revenue was negatively impacted by several million dollars due to the price of helium. The price of helium gradually reduced during 2022 and into 2023. Based on projections that we see, we believe the price of helium may continue to reduce during the first half of 2023 to a more typical range. The longer the price of helium exceeds a normal range, the more negatively our business will be impacted.

 

The efficient trading of our common stock on an appropriate platform.

 

Twice during 2022 we were informed by Nasdaq that the bid price of our common stock had been below $1 for an extended period of time and that we risked being delisted if that problem was not satisfactorily resolved. As of January 19, 2023, we received confirmation from the Nasdaq that we had regained compliance with the minimum bid requirement for continued listing.

 

9

 

Item No. 1B – Unresolved Staff Comments

 

As of the filing of this Annual report on Form 10-K, we had no unresolved comments from the staff of the Securities and Exchange Commission.

 

Item No. 2 – Properties

 

We executed a sale and leaseback transaction during 2021 on our principal plant and offices located in Lake Barrington, Illinois, approximately 45 miles northwest of Chicago, Illinois. The facility includes approximately 68,000 square feet of office, manufacturing and warehouse space. The lease is for ten years, and annual rent increases from $500,000 the first year to $652,000 during the final year.

 

During 2021 we entered into a sublease agreement, which was extended during 2022, now expiring on December 31, 2025 to rent approximately 69,000 square feet of warehouse and assembly space in Elgin, Illinois. The annual lease cost for this facility will rise to $445,000 during the final year of the lease.

 

We believe that our properties have been adequately maintained, are in generally good condition and are suitable for our business as presently conducted. We believe our existing facilities provide sufficient production capacity for our present needs and for our presently anticipated needs in the foreseeable future. We also believe that, with respect to leased properties, upon the expiration of our current leases, we will be able to either secure renewal terms or to enter into leases for alternative locations at market terms.

 

Item No. 3 – Legal Proceedings

 

The Company may be party to certain lawsuits or claims arising in the normal course of business. The ultimate outcome of these matters is unknown but, in the opinion of management, we do not believe any of these proceedings will have, individually or in the aggregate, a material adverse effect upon our financial condition, cash flows or future results of operation.

 

Item No. 4. – Mine Safety Disclosures

 

Not Applicable.

 

PART II

 

Item No. 5 – Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

 

Market Information

 

The Company’s common stock was admitted to trading on the NASDAQ SmallCap Market (now the NASDAQ Capital Market) under the symbol “CTIB” on November 5, 1997.

 

As of December 31, 2022 there were approximately 400 holders of record of the Company’s Common Stock. The Company’s total number of beneficial owners of common stock of the Company was approximately 30.

 

The Company did not pay any cash dividends on its Common Stock during 2022 or 2021 and has no plans to pay dividends in the foreseeable future. Under the terms of the Company’s current loan agreements, the amount of dividends the Company may pay is limited by the terms of the financial covenants. During 2022 the Company received three deficiency notices from NASDAQ – one for the failure to hold an annual meeting of shareholders during 2021, and the other two for failure to maintain the required $1 bid price during a 30 day period in 2022. The Company held an annual meeting on June 17, 2022, which resolved the first deficiency. The Company’s common stock achieved the required bid price during 2022, resolving the first bid price deficiency, but subsequently fell below the required bid price and remained there for six months. NASDAQ provided the Company a notice of delisting in November 2022, which the Company appealed. A hearing was held on January 5, 2023 on this matter. Subsequently, on January 19, 2023, NASDAQ confirmed that the Company had regained compliance with the continued listing standard related to minimum bid price.

 

On March 14, 2023, our common stock closed at $1.97 per share.

 

10

 

Equity Compensation Plan Information

 

There were no stock option incentive plans outstanding as of December 31, 2022. Effective January 2022, the Company issued an inducement grant to its newly hired Chief Executive Officer for 250,000 shares of restricted stock. 25,000 of those shares vested during January 2022, while the remaining shares were subject to achievement of certain performance conditions. 56,250 of these remaining shares vested during 2022 when the Company refinanced the terms of its credit facility. The Company also provided a grant of shares of restricted stock to its Chief Operating Officer, with 20,000 shares vesting over 12 months and the remaining 80,000 shares vesting based on performance criteria being met. Of these remaining shares, 20,000 subsequently vested when the Company refinanced the terms of its credit facility.

 

Item No. 6 – Selected Financial Data

 

We are a smaller reporting company, as defined by Rule 12b-2 of the Securities Exchange Act of 1934, as amended, and are not required to provide the information required under this item.

 

Item No. 7 – Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Overview

 

The Company produces film products for novelty, packaging container and custom film product applications. These products include foil balloons, latex balloons (sourced from an external party) and related products, films for packaging applications, and custom film products. We produce all of our film products for packaging and container applications at our facilities in Lake Barrington, Illinois. Substantially all of our film products for packaging applications and flexible containers for packaging and storage are sold to customers in the United States. We market and sell our novelty items – principally foil balloons and latex balloons – in the United States and a number of additional countries. In addition, the Company assembles and sells Candy Blossoms (containers of arranged candy items) in the United States.

 

As determined by the Board of Directors beginning in 2019, we have been exiting our foreign operations in order to focus on our North American operations, particularly on foil balloons and related products. The sales entity in the UK was liquidated in 2019. The sales and distribution entity in Germany was fully closed during 2021. As noted herein, we sold Flexo Universal, our Mexican manufacturing subsidiary, during October 2021. Additionally, we stopped selling our vacuum sealing products as of March 30, 2020, after allowing the related license agreement to expire. More discussion is available in discontinued operations in this Annual Report on Form 10-K (see Note 19).

 

We have also changed our capital structure, beginning January 2020. This includes:

 

Series A Preferred Stock

 

On January 3, 2020, the Company entered into a stock purchase agreement (as amended on February 24, 2020 and April 13, 2020 (the “LF Purchase Agreement”)), pursuant to which the Company agreed to issue and sell, and LF International Pte. Ltd., a Singapore private limited company (“LF International”), which is controlled by Company Chairman, Mr. Yubao Li, agreed to purchase, up to 500,000 shares of the Company’s newly created shares of Series A Preferred Stock (“Series A Preferred”), with each share of Series A Preferred initially convertible into ten shares of the Company’s common stock, at a purchase price of $10.00 per share, for aggregate gross proceeds of $5,000,000 (the “LF International Offering”). As permitted by the Purchase Agreement, the Company may, in its discretion issue up to an additional 200,000 shares of Series A Preferred for a purchase price of $10.00 per share (the “Additional Shares Offering,” and collectively with the LF International Offering, the “Offering”). Approximately $1 million of Series A Preferred has been sold as of June 30, 2021, including to an investor which converted an account receivable of $478,000 owed to the investor by the Company in exchange for 48,200 shares of Series A Preferred. The Company completed several closings with LF International from January 2020 through June 2020. The majority of the funds received reduced our bank debt. We issued a total of 400,000 shares of common stock to LF International and, pursuant to the LF Purchase Agreement, changed our name from CTI Industries Corporation to Yunhong CTI Ltd. LF International had the right to name three directors to serve on our Board. They were Mr. Yubao Li, Ms. Wan Zhang and Ms. Yaping Zhang, the latter two of whom retired from our Board of Directors during January 2022. In the three and nine months ended September 30, 2022, the Company accrued $67,000 and $267,000 of these dividends in each period, respectively. On September 1, 2022, the investor converted Preferred Series A into 5 million shares of common stock and approximately 1.3 million shares of common stock representing accrued dividends.

 

11

 

Series B Preferred Stock

 

In November 2020, we issued 170,000 shares of Series B Preferred for an aggregate purchase price of $1,500,000. The Series B Preferred have an initial stated value of $10.00 per share and liquidation preference over common stock. The Series B Preferred is convertible into shares of our common stock equal to the number of shares determined by dividing the sum of the stated value and any accrued and unpaid dividends by the conversion price of $1.00. The Series B Preferred accrues dividends at a rate of 8 percent per annum, payable at our election either in cash or shares of the Company’s common stock. Initially, the Series B Preferred, in whole or part, was redeemable at the option of the holder (but not mandatorily redeemable) at any time on or after November 30, 2021 for the stated value, plus any accrued and unpaid dividends and thus was classified as mezzanine equity and initially recognized at fair value of $1.5 million (the proceeds on the date of issuance). In March 2021, the terms of the Series B Preferred were modified to eliminate the ability of the holder to redeem the Series B Preferred. The carrying value as of December 31, 2022 and 2021 amounted to $1,851,000 and $1,715,000, respectively. The December 31, 2022 balance consists of $1,500,000 original carrying value, $304,000 accrued dividends and $47,000 accretion. During February 2023, the investor converted Series B into approximately 1.9 million shares of common stock.

 

Series C Preferred Stock

 

In January 2021 we entered into an agreement with a related party, LF International Pte. Ltd. which is controlled by Company director, Chairman, President and Chief Executive Officer, Mr. Yubao Li, to purchase shares of Series C Preferred stock. We issued 170,000 shares of Series C Preferred for an aggregate purchase price of $1,500,000. The Series C Preferred have an initial stated value of $10.00 per share and liquidation preference over common stock. The Series C Preferred is convertible into shares of our common stock equal to the number of shares determined by dividing the sum of the stated value and any accrued and unpaid dividends by the conversion price of $1.00. The carrying value as of September 1, 2022 and December 31, 2021 amounted to $1,698,000 and $1,630,000, respectively. On September 1, 2022, the investor converted Series C into 1.7 million shares of common stock and accrued dividends in the amount of approximately 0.3 million shares of common stock.

 

Series D Preferred Stock

 

In June 2021, the Company received $1.5 million from an unrelated third party as an advance on a proposed sale of Series D Redeemable Convertible Preferred Stock, which was ultimately completed. The Series D Preferred have an initial stated value of $10.00 per share and liquidation preference over common stock. The Series D Preferred is convertible into shares of our common stock equal to the number of shares determined by dividing the sum of the stated value and any accrued and unpaid dividends by the conversion price of $1.00. We issued 170,000 shares of Series D Preferred for an aggregate price of $1.5 million. Additionally, 128,000 warrants were issued pursuant to this transaction which are convertible into our common stock at the lesser of $1.75 per share or 85% of the volume weighted average price of the shares over the ten trading days prior to conversion. The carrying value as of September 1, 2022 and December 31, 2021 amounted to $1,580,000 and $1,512,000, respectively. On September 1, 2022, the investor converted Preferred Series D into 1.7 million shares of common stock and received accrued dividends of approximately 0.1 million shares of common stock.

 

Preferred Stock
Rollforward		  Balance as of
December 31, 2021		   Accrued Deemed
Dividends		   Balance as of
December 31, 2022		 
Series B   1,715,000    136,000    1,851,000 

 

Warrants

 

A summary of the Company’s stock warrant activity is as follows:

 

   Shares under
Option		   Weighted
Average
Exercise
Price		 
Balance at December 31, 2021   128,000   $1.75 
Granted   -    - 
Cancelled/Expired   -    - 
Exercised/Issued   -    - 
Outstanding at December 31, 2022   128,000    1.75 
           
Exercisable at December 31, 2022   128,000   $1.75 

 

As of December 31, 2022 the Company reserved the following shares of its common stock for the exercise of warrants, and preferred stock:

 

Series B Preferred Stock   1,700,000 
2021 Warrants   128,572 
Shares reserved as of December 31, 2022   1,828,572 

 

12

 

Effective January 2022, and in accordance with the Employment Agreement of Chief Executive Officer Frank Cesario, a grant of restricted stock was made in the amount of 250,000 shares. 25,000 shares vested immediately, while the remaining 225,000 are subject to performance conditions as further detailed in the share grant. Specifically, the restrictions on the remaining 225,000 shares will lapse based on satisfaction of the following performance goals and objectives and continued employment through the date of meeting such targets:

 

● The restrictions on 56,250 shares of the award will lapse and the award will vest when the Company’s trailing-twelve-month EBITDA equals or exceeds $1 million at any time on or after January 1, 2022.

● The restrictions on 56,250 shares of the award will lapse and the award will vest in the event the Company’s common shares trade at or above $5/share for ten or more consecutive trading days.

● The restrictions on 56,250 shares of the award will lapse and the award will vest when the Company’s operating cash flow, calculated cumulatively from the date of employment, equals or exceeds $1.5 million. On February 16, 2023, the Compensation Committee determined this condition had been satisfied.

● The restrictions on 56,250 shares of the award will lapse and the award will vest in the event the Company is able to refinance its current lender with a traditional lender on terms and conditions customary for such financing. On August 23, 2022, the Compensation Committee determined this condition had been satisfied with an amended agreement with the Company’s lender.

 

During 2022, the Compensation Committee awarded the Company’s Chief Operating Officer a grant of 100,000 shares of restricted stock. 20,000 of those shares vest over a 12 month period while the remaining shares vest 20,000 each based on the performance conditions above.

 

The Compensation Committee (as defined in the Plan) shall be responsible for determining when the conditions above have been satisfied. The Company records compensation expense with each vesting, and records a likelihood of vesting weighted analysis to the extent it has visibility to do so. Without such visibility, it considers such probability as de minimis until additional information is available.

 

Our revenues from continuing operations from each of our product categories in each of the past two years have been as follows:

 

   Twelve Months Ended 
   December 31, 2022   December 31, 2021 
   $   % of   $   % of 
Product Category  (000) Omitted   Net Sales   (000) Omitted   Net Sales 
                 
Foil Balloons   10,858    60%   18,235    76%
                    
Film Products   2,036    11%   2,386    10%
                    
Other   5,154    29%   3,464    14%
                    
Total   18,048    100%   24,086    100%

 

13

 

Our primary expenses include the cost of products sold and selling, general and administrative expenses.

 

Cost of products sold primarily consists of expenses related to raw materials, labor, quality control and overhead expenses such as supervisory labor, depreciation, utilities expense and facilities expense directly associated with production of our products, warehousing and fulfillment expenses and shipping costs relating to the shipment of products to customers. Cost of products sold is impacted by the cost of the raw materials used in our products, the cost of shipping, along with our efficiency in managing the production of our products.

 

Selling, general and administrative expenses include the compensation and benefits paid to our employees, all other selling expenses, marketing, promotional expenses, travel and other corporate administrative expenses. These other corporate administrative expenses include professional fees, depreciation of equipment and facilities utilized in administration, occupancy costs, communication costs and other similar operating expenses. Selling, general and administrative expenses can be affected by a number of factors, including staffing levels and the cost of providing competitive salaries and benefits, the cost of regulatory compliance and other administrative costs.

 

Purchases by a limited number of customers represent a significant portion of our total revenues. During 2022 and 2021, respectively, sales to our top 10 customers represented 90% and 85%, respectively, of net revenues for each year. During 2022 and 2021, there were two customers to whom our sales represented more than 10% of net revenues.

 

Our principal customer sales for 2022 and 2021 were:

 

Customer  Product  2022 Sales  

% of 2022

Revenues

   2021 Sales  

% of 2021

Revenues

 
Wal-Mart  Balloons; Candy Blossoms  $6,497,000    35%  $4,537,000    19%
Dollar Tree Stores  Balloons  $6,729,000    36%  $13,813,000    57%

 

The loss of one or both of these principal customers, or a significant reduction in purchases by one or both of them, could have a material adverse effect on our business.

 

We generally do not have agreements with our customers under which customers are obligated to purchase any specific or minimum amount of product from us.

 

Year Ended December 31, 2022 Compared to Year Ended December 31, 2021

 

Net Sales

 

For the fiscal year ended December 31, 2022, consolidated net sales from continuing operations of the sale of all products were $18,048,000 compared to consolidated net sales of $24,086,000 for the year ended December 31, 2021, a decrease of 25% as more fully described below.

 

Sales of foil balloons were $10,858,000 in 2022 and $18,235,000 in 2021, a decrease of 40%. Our largest customer for foil balloons was Dollar Tree Stores. The remaining sales were made to hundreds of customers including distributors and retail stores. The first half of 2022 saw a significant increase in the price of helium which gradually reduced as the year progressed and into 2023. As most of our foil balloons are ultimately filled with helium, this was the primary reason for the decline in sales related to the prior year.

 

Sales of film products were $2,036,000 in 2022 and $2,386,000 in 2021, a decrease of 15%. Our second largest customer entered 2022 with excess inventory and only started placing orders for new material during the second half of the year. Our largest customer purchased more material than usual during the first nine months of the year, ending with sufficient material not to need new material during the last three months of 2022.

 

Sales of other products increased to $5,154,000 in 2022 from $3,464,000 in 2021, an increase of 49%. This category includes sales of Candy Blossoms, which featured larger holiday orders than the prior year as well as the launch of an everyday offering.

 

Cost of Sales

 

Cost of sales decreased to $14,910,000 in 2022 from $20,321,000 in 2021, a decrease of 27%. The decrease in cost of sales was primarily attributable to the decrease in sales.

 

14

 

General and Administrative Expenses

 

General and administrative expenses increased to $3,720,000 in 2022 from $3,815,000 in 2021, a decrease of 2%.

 

Selling and Marketing

 

Selling expenses from continuing operations increased to $136,000 in 2022 from $132,000 in 2021. Marketing and advertising expense increased to $402,000 in 2022, from $323,000 in 2021, an increase of 21%.

 

Other Income or Expense

 

During 2022, we incurred net interest expense of $450,000 compared to net interest expense of $564,000 during 2021. The decrease in interest expense was primarily attributable to the lower average outstanding balance of debt in 2022 as compared to 2021.

 

During 2021 we engaged in a Sale and Leaseback transaction of our principal headquarters in Lake Barrington, IL. This transaction resulted in a gain of $3.4 million. We also recorded an expense related to the disposition of our Flexo Universal subsidiary. We recorded an approximately $10 million expense in Other Expense and a $6 million gain in Other Comprehensive Income related to this transaction, all non-cash items.

 

Deemed Dividends on Preferred Stock and Amortization of Beneficial Conversion Feature

 

In 2020 the Company issued Series A Preferred Stock and Series B Preferred Stock. In connection with these preferred stock issuances, and the related beneficial conversion features, the Company had deemed dividends of $4.4 million in 2020. During 2021, the Company issued Series C Preferred Stock and Series D Preferred Stock. In connection with all of these preferred stock issuances, and the related beneficial conversation features, the Company had deemed dividends of $0.6 million during 2022 and $3.6 million during 2021. Although these deemed dividends do not impact Net loss attributable to Yunhong CTI, Ltd., they do impact Net loss attributable to Yunhong CTI Ltd. Common Shareholders and EPS. As Series A, C and D preferred stock all converted during 2022, only Series B preferred stock dividends remained on an ongoing basis. Series B converted into common during 2023, ending the related dividend accrual.

 

Financial Condition, Liquidity and Capital Resources

 

Cash (Used In) Provided By Operating Activities

 

During 2022, cash generated by operating activities amounted to $2,368,000, compared to cash used by operating activities during 2021 of ($3,710,000). Significant changes in working capital items affecting cash flow used in operating activities were:

 

  ● Depreciation and amortization of $383,000 compared to depreciation and amortization for 2021 of $462,000;
  ● An increase in inventories of $449,000 compared to an increase in inventories of $604,000 in 2021;
  ● An decrease in accounts receivable of ($1,825,000) compared to an increase in accounts receivable of $1,673,000 in 2021;
  ● A decrease in prepaid expenses and other assets of ($836,000) compared to a decrease in prepaid expenses and other assets of ($132,000) in 2021; and
  ● A decrease in trade payables of ($819,000) compared to a decrease in trade payables of ($1,173,000) in 2021.

 

Cash Provided By (Used In) Investing Activities

 

During fiscal 2022, cash used in investing activities amounted to ($163,000) compared to cash provided by investing activities during fiscal 2021 of $3,378,000.

 

15

 

Cash Provided By (Used In) Financing Activities

 

During fiscal 2022, cash used by financing activities amounted to ($2,125,000), compared to cash provided by financing activities of $626,000 during fiscal 2021

 

In October 2020, we received an advance of $1,500,000 from an investor. In January 2021, we finalized the transaction with the investor and issued 170,000 shares of newly authorized Series C Preferred Stock.

 

In June 2021, the Company received $1.5 million from an investor as an advance on a proposed sale of Series D Redeemable Convertible Preferred Stock, which has since occurred. We issued 170,000 shares of newly authorized Series D Preferred Stock and 128,000 warrants to purchase our common stock.

 

Going Concern, Liquidity and Financial Condition

 

The Company’s financial statements are prepared using account principles generally accepted in the United States (“U.S. GAAP”) applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has a cumulative net loss from inception to December 31, 2022 of approximately $24 million. The accompanying financial statements for the year ended December 31, 2022 have been prepared assuming the Company will continue as a going concern. The Company’s cash resources may be insufficient to meet its anticipated needs during the next twelve months. The Company may require additional financing to fund it future planned operations. The ability of the Company to continue as a going concern is dependent on the Company’s execution of its business plans and the ability to raise any needed additional capital at acceptable terms to the Company. While Management plans to mitigate this issue with improved performance now that it has disposed of subsidiaries and their related losses, there can be no guarantee this will be successful. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 

During December 2017, we entered in new financing agreements with PNC Bank, National Association (“PNC”). The financing agreements with PNC (the “PNC Agreements”) included a $6 million term loan and an $18 million revolving credit facility (the “Revolving Credit Facility”), with a credit facility termination date of December 2022. Available credit under the Revolving Credit facility was determined by eligible receivables and inventory at CTI Industries (U.S.) and Flexo Universal (Mexico).

 

We notified PNC of our failure to meet certain financial covenants and conditions during multiple occasions between 2018 and 2021, resulting in amendments to the loan documents, and in some cases forbearance agreements, along with related fees, penalties and other conditions.

 

On September 30, 2021 (the “Closing Date”), the Company entered into a loan and security agreement (the “Agreement”) with Line Financial (the “Lender”), which provides for a senior secured financing consisting of a revolving credit facility (the “Revolving Credit Facility) in an aggregate principal amount of up to $6 million (the “Maximum Revolver Amount”) and term loan facility (the “Term Loan Facility”) in an aggregate principal amount of $731,250 (“Term Loan Amount” and, together with the Revolving Credit Facility, the “Senior Facilities”). Proceeds of loans borrowed under the Senior Facilities were used to repay all amounts outstanding under the Company’s PNC Agreements and for the Company’s working capital. The Senior Facilities are secured by substantially all assets of the Company. The Company has been in compliance with the terms of these Senior Facilities since inception in September 2021.

 

Interest on the Senior Facilities shall be the prime rate published from time to time published in the Wall Street Journal (7.5% as of December 16, 2022), plus 1.95% per annum, accruing daily and payable monthly. Interest shall be calculated on the basis of a 360-day year for the actual number of days elapsed. The Term Loan Facility shall be repaid by the Company to Lender in 48 equal monthly installments of principal and interest, each in the amount of $15,234, commencing on November 1, 2021, and continuing on the first day of each month thereafter until the Term Loan Maturity Date (as defined in the Agreement). Also, the Company was to pay the Lender collateral monitoring fees of 4.62% of the eligible accounts receivable, inventory, and equipment supporting the Revolving Credit Facility and the Term Loan. During August 2022 the terms above were modified to reduce the collateral monitoring fee to 2.77%, and added a provision that barred the Company from repaying the facility prior to September 2023. In addition, the Company paid the Lender a loan fee of 1.25% of the Maximum Revolver Amount and the Term Loan Amount upon the execution of the Agreement.

 

16

 

The Senior Facilities mature on September 30, 2023 and shall automatically be extended for successive periods of one year each, unless the Company or the Lender gives the other party written notice of termination not less than 90 days prior to the end of such term or renewal term, as applicable. If the Senior Facilities are renewed, the Company shall pay the Lender a renewal fee of 1.25% of the Maximum Revolver Amount and the Term Loan Amount upon each renewal on the anniversary of the Closing Date. The Company has the option to prepay the Term Loan Facility (together with all accrued but unpaid interest and a Term Loan Prepayment Fee (as defined the Agreement) in whole, but not in part, upon not less than 60 days prior written notice to the Lender.

 

The Senior Facilities require that the Company shall, commencing December 31, 2021, maintain Tangible Net Worth of at least $4,000,000 or greater (“Minimum Tangible Net Worth”). Minimum Tangible Net Worth may be adjusted downward by the Lender, from time to time, in its sole and absolute discretion, based on the effect of non-cash charges and other factors on the calculation of Tangible Net Worth. Other debt subordinated to Lender is not considered as a reduction of this calculation.

 

The Senior Facilities contain certain affirmative and negative covenants that limit the ability of the Company, among other things and subject to certain significant exceptions, to incur debt or liens, make investments, enter into certain mergers, consolidations, and acquisitions, pay dividends and make other restricted payments, or make capital expenditures exceeding $1,000,000 in the aggregate in any fiscal year.

 

As of January 1, 2019, the Company had a note payable to John H. Schwan, former Director and former Chairman of the Board, for $1.6 million, including accrued interest. This loan accrues interest, is due on demand, and is subordinate to the Senior Facilities. During January 2019, Mr. Schwan converted $600,000 of the note into approximately 181,000 shares of our common stock at the then market rate of $3.32 per share. As a result of the conversion, the loan balance decreased to $1.0 million. The loan and interest payable to Mr. Schwan amounted to $1.3 million and $1.2 million as of December 31, 2022 and December 31, 2021, respectively. No payments were made to Mr. Schwan during 2022 or 2021. Interest expense related to this loan amounted to approximately $74,000 and $70,000 for the twelve months ended December 31, 2022 and 2021, respectively.

 

As of December 31, 2021, the Company had a note payable to Alex Feng for $166,667. This loan accrues interest at 3% and is subordinate to the Senior Facilities. The subordination agreement signed September 30, 2021 changed the term of the maturity date from November 2023 to March 2024 and payment date starting April 2022.

 

In October 2020, the Company received $1.5 million from an unrelated third party as an advance on a proposed sale of Series C Redeemable Convertible Preferred Stock. As of December 31, 2020, the Company was in the process of negotiating and finalizing the terms of the arrangement, which has since occurred. As the agreement was not finalized as of December 31, 2020, the $1.5 million advance was classified as Advance from Investor within liabilities on the accompanying balance sheet and subsequently reclassified as stockholders equity. During 2021, $1.5 million was received for a series D Redeemable Convertible Preferred Stock and 128,000 warrants to purchase our common stock.

 

Through September 30, 2022, the Company has received approximately $160,000 in Employee Retention Tax Credits (“ERTC”) from the United States Government related to claims that were filed during 2021. $123,000 is listed as General and Administrative, while the remainder is in Other Income. During October 2022 the Company executed a financing transaction wherein the remaining open claims for $1.2 million in ERTC was sold to a third party for $0.9 million. Once the $1.2 million is ultimately paid, those funds will be immediately transferred to the third party . To the extent any of the $1.2 million in ERTC claims are determined by the United States Government not to be payable, a prorated portion of the $0.9 million must be returned to that investor. The $0.9 million is listed as a deferred income current liability as of December 31, 2022, which will be recognized upon acceptance and processing of the amended returns by the United States Government. During January 2023, approximately $0.8 million of claims had been processed and refunds issued, which was forwarded to the third party above. As a result, approximately $0.6 million of the deferred income liability was recognized during January 2023.

 

Seasonality

 

In the foil balloon product line, sales have historically been seasonal. Approximately half of these sales are considered “everyday” in nature while the other half tend to be event driven (certain holidays, graduation season, and other events). The COVID-19 pandemic changed the shape of graduation season for 2020, resulting in a lower demand for balloons during the second quarter 2020, but then a surge of demand related to at-home parties and events. This increase in demand continued in 2021. As 2022 returned to a more standardized calendar of events relative to COVID-19, the sales activities returned to a more traditional shape (excluding the impact of helium pricing).

 

Critical Accounting Policies

 

The financial statements of the Company are based on the selection and application of significant accounting policies which require management to make various estimates and assumptions. The following are some of the more critical judgment areas in the application of our accounting policies that currently affect our financial condition and results of operation.

 

17

 

Revenue Recognition. Substantially all of the Company’s revenues are derived from the sale of products. With respect to the sale of products, revenue from a transaction is recognized once it has (i) identified the contract(s) with a customer, (ii) identified the performance obligations in the contract, (iii) determined the transaction price, (iv) allocated the transaction price to the performance obligations in the contract, and (v) recognized revenue as the company satisfies a performance obligation. The Company generally recognizes revenue for the sale of products when the products have been shipped and invoiced. In some cases, product is provided on consignment to customers. In those cases, revenue is recognized when the customer reports a sale of the product.

 

The Company adopted Accounting Standards Codification (ASC) Topic 606, Revenue from Contracts with Customers. Our revenue arrangements generally consist of a single performance obligation to transfer promised goods at a fixed price.

 

Net sales include revenues from sales of products and shipping and handling charges, net of estimates for product returns. Revenue is measured at the amount of consideration the Company expects to receive in exchange for the transferred products. Revenue is recognized at the point in time when we transfer the promised products to the customer and the customer obtains control over the products. The Company recognizes revenue for shipping and handling charges at the time the goods are shipped to the customer, and the costs of outbound freight are included in cost of sales, as we have elected the practical expedient included in ASC 606.

 

The Company provides for product returns based on historical return rates. While we incur costs for sales commissions to our sales employees and outside agents, we recognize commission costs concurrent with the related revenue, as the amortization period is less than one year and we have elected the practical expedient included in ASC 606. We do not incur incremental costs to obtain contracts with our customers. Our product warranties are assurance-type warranties, which promise the customer that the products are as specified in the contract. Therefore, the product warranties are not a separate performance obligation and are accounted for as described herein. Sales taxes assessed by governmental authorities are accounted for on a net basis and are excluded from net sales.

 

Allowance for Doubtful Accounts. We estimate our allowance for doubtful accounts based on an analysis of specific accounts, an analysis of historical trends, payment and write-off histories. Our credit risks are continually reviewed, and management believes that adequate provisions have been made for doubtful accounts. However, unexpected changes in the financial condition of customers or changes in the state of the economy could result in write-offs which exceed estimates and negatively impact our financial results.

 

Inventory Valuation. Inventories are stated at the lower of cost or net realizable value. Cost is determined using standard costs which approximate costing determined on a first-in, first out basis. Standard costs are reviewed and adjusted at the time of introduction of a new product or design, periodically and at year-end based on actual direct and indirect production costs. On a periodic basis, the Company reviews its inventory levels for estimated obsolescence or unmarketable items, in reference to future demand requirements and shelf life of the products. As of December 31, 2022, the Company had established a reserve for obsolescence, marketability or excess quantities with respect to inventory in the aggregate amount of $155,000. As of December 31, 2021, the amount of the reserve was $290,000. In addition, on a periodic basis, the Company disposes of inventory deemed to be obsolete or unsaleable and, at such time, charges reserve for the value of such inventory. We record freight income as a component of net sales and record freight costs as a component of cost of goods sold.

 

Valuation of Long-Lived Assets. We evaluate whether events or circumstances have occurred which indicate that the carrying amounts of long-lived assets (principally property and equipment and goodwill) may be impaired or not recoverable. Significant factors which may trigger an impairment review include: changes in business strategy, market conditions, the manner of use of an asset, underperformance relative to historical or expected future operating results, and negative industry or economic trends. We apply the provisions of generally accepted accounting principles in the United States of America (“U.S. GAAP”) U.S. GAAP, under which goodwill is evaluated at least annually for impairment.

 

18

 

Foreign Currency Translation. All balance sheet accounts are translated using the exchange rates in effect at the balance sheet date. Statements of operations amounts are translated using the average exchange rates for the year-to-date periods. The gains and losses resulting from the changes in exchange rates during the period have been reported in other comprehensive income or loss, except that, on November 30, 2012, the Company determined that it does have an expectation of receiving payment with respect to indebtedness of Flexo Universal to the Company, and accordingly, as of and after that date foreign currency gains and losses with respect to such indebtedness has been reported in the statement of operations. This issue became moot with the sale of Flexo Universal during October 2021, which followed the elimination of other foreign subsidiaries (UK and Germany).

 

Stock-Based Compensation. We follow U.S. GAAP which requires all stock-based payments to employees, including grants of employee stock options, to be recognized in the consolidated financial statements based on their grant-date fair values.

 

We use the Black-Scholes option pricing model to determine the fair value of stock options which requires us to estimate certain key assumptions. In accordance with the application of U.S. GAAP, we incurred no employee stock-based compensation cost for the year ended December 31, 2022. At December 31, 2022, we had approximately $3,000 unrecognized compensation cost relating to stock options, as well as performance based awards for which the ultimate vesting is unknown.

 

Income Taxes and Deferred Tax Assets. Income taxes are accounted for as prescribed in U.S. GAAP. Under the asset and liability method of U.S. GAAP, the Company recognizes the amount of income taxes currently payable. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities, and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years these temporary differences are expected to be recovered or settled.

 

We evaluate all available positive and negative evidence in each tax jurisdiction regarding the recoverability of any asset recorded in our Consolidated Balance Sheets and provide valuation allowances to reduce our deferred tax assets to an amount we believe is more likely than not to be realized. We regularly review our deferred tax assets for recoverability considering historical profitability, our ability to project future taxable income, the expected timing of the reversals of existing temporary differences and tax planning strategies. If we continue to operate at a loss in certain jurisdictions or are unable to generate sufficient future taxable income within the defined lives of such assets, we could be required to increase our valuation allowance against all or a significant portion of our deferred tax assets. This increase in valuation allowance could result in substantial increases in our effective tax rate and could have a material adverse impact on our operating results. Conversely, if and when our operations in some jurisdictions become sufficiently profitable before what we have estimated in our current forecasts, we would be required to reduce all or a portion of our current valuation allowance and such reversal would result in an increase in our earnings in such period.

 

Prior to September 30, 2021, we had been out of compliance with the terms of our credit facility and operating under a forbearance agreement, and had related going concern disclosure. We therefore established a valuation allowance reserve for substantially all of our deferred tax assets. As of December 31, 2022 and 2021, the amount of the net deferred tax asset was none, as we continued to record a valuation allowance against the gross value of the deferred tax asset. Each quarter and year-end, management makes a judgment to determine the extent to which the deferred tax asset will be recovered from future taxable income. This value was reduced, in large part, due to changes in US tax law effective 2018 which will impact the value of future deductions.

 

Fair Value Measurements. U.S. GAAP defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the quality of inputs used to measure fair value and enhances disclosure requirements for fair value measurements. U.S. GAAP clarifies that fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. U.S. GAAP also requires that a fair value measurement reflect the assumptions market participants would use in pricing an asset or liability based upon the best information available. In February 2008, the FASB issued guidance now codified in U.S. GAAP which provides for delayed application of certain guidance related to non-financial assets and non-financial liabilities, except for items that are recognized or disclosed at fair value in the financial statements on a recurring basis (at least annually).

 

19

 

Item No. 7A – Qualitative and Quantitative Disclosures Regarding Market Risk

 

Not applicable.

 

Item No. 8 – Financial Statements and Supplementary Data

 

Reference is made to the Consolidated Financial Statements contained in Part IV hereof.

 

Item No. 9 – Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

 

None.

 

Item No. 9A – Controls and Procedures

 

(a) Evaluation of Disclosure Controls and Procedures

 

We maintain disclosure controls and procedures, as such term is defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 (the “Exchange Act”), that are designed to ensure that information required to be disclosed in the reports filed or submitted under the Exchange Act, is recorded, processed, summarized, and reported within the time periods specified by the Commission’s rules and forms. Disclosure controls and procedures include controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act are properly recorded, processed, summarized and reported within the time periods required by the Commission’s rules and forms.

 

We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer (principal executive officer) and Chief Financial Officer (principal financial officer), of the effectiveness of the design and operation of these disclosure controls and procedures, as such term is defined in Exchange Act Rule 13a-15(e), as of December 31, 2022. Based on this evaluation, the Chief Executive Officer (principal executive officer) and Chief Financial Officer (principal financial officer) concluded that our disclosure controls and procedures were not effective as of December 31, 2022, the end of the period covered by this Annual Report on Form 10-K, due to the material weaknesses described below.

 

(b) Management’s Report on Internal Control over Financial Reporting

 

Management of the Company is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act.

 

Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness of internal control over financial reporting to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

Management has assessed the effectiveness of our internal control over financial reporting as of December 31, 2022. In making our assessment of the effectiveness of internal control over financial reporting, management used the criteria set forth in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”).

 

20

 

A material weakness is a control deficiency, or combination of control deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of the registrant’s annual or interim financial statements will not be prevented or detected on a timely basis. As a result of our evaluation of our internal control over financial reporting, management identified the following material weaknesses in our internal control over financial reporting:

 

  ● We lacked a sufficient number of accounting professionals with the necessary knowledge, experience and training to adequately account for significant, unusual transactions that resulted in misapplications of GAAP, particularly with regard to the timing of recognition of certain non-cash charges, and
  ● We are overly dependent upon our Acting Chief Financial Officer, who at present is our Chief Executive Officer, within an environment that is highly manual in nature

 

Management concluded that there is a reasonable possibility that a material misstatement could occur in the consolidated financial statements if the control deficiencies were not remediated. Accordingly, management concluded that the matters described above are material weaknesses in the Company’s internal control over financial reporting and that the Company did not maintain effective internal control over financial reporting as of December 31, 2022.

 

Plan for Remediation of Material Weakness

 

Management has enhanced its available resource base and adjusted its processes with respect to the areas listed above. Additional procedures are in the process of being established and will be evaluated for effectiveness in the future. Two individuals were engaged to perform the duties of controller during 2022, but neither remains with the Company as of December 31, 2022. Further, the Company views the combination of Acting Chief Financial Officer duties with the Chief Executive Officer as temporary in nature.

 

This annual report does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by its registered public accounting firm pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act, which permits the Company to provide only management’s report in this annual report.

 

(c) Changes in Internal Control over Financial Reporting

 

There were no changes in our internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act, during our most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

Item No. 9B – Other Information

 

None

 

PART III

 

Item No. 10 – Directors, Executive Officers and Corporate Governance of the Registrant

 

The members of our Board of Directors (the “Board”), and our executive officers, together with their respective ages and certain biographical information are set forth below. Directors hold office until the next annual meeting of our stockholders and until their successors have been duly elected and qualified. Our executive officers are elected by and serve at the designation and appointment of the Board.

 

The following is a brief account of the business experience of each of our directors and executive officers during the past five years or more.

 

Name   Age   Position
Yubao Li   41   Chairman of the Board of Directors
Frank J. Cesario   53   Chief Executive Officer and Director; Acting Chief Financial Officer
Jana M. Schwan   46   Chief Operating Officer
Douglas Bosley   55   Director
Gerald (J.D.) Roberts, Jr.   63   Director
Philip Wong   44   Director

 

21

 

Yubao Li, Chairman of the Board of Directors. Mr. Li has served as a Director of the Company since January 13, 2020 and was elected as Chairman of the Board on June 1, 2020. Mr. Li served as the Company’s Chief Executive Officer from September 2020 until January 2022. Mr. Li has been serving as the Chairman of Yunhong International since its inception in January 2019 and served as its Chief Executive Officer from January 2019 to September 2019. Mr. Li has been serving as the president of Hubei Academy of Science and Technology Service Station since July 2018. Since June 2018, Mr. Li has been serving as the Director of Photoproteins Research Centre at China’s Academy of Management Science, a research institute situated in Beijing where he supports innovation by defining the research focus of the group. Mr. Li also serves as a director and/or officer of several other entities, including as the Executive Director and General Manager of Hubei Teruiga Energy Co., Ltd, a new energy technology company, since November 2017, the Executive Director of Hubei Yuntong Energy Co., Ltd., a solar power and agriculture company, since April 2016, the Executive Director and General Manager of Hubei Yun Hong photovoltaic Co., Ltd., a solar power and agriculture company, since May 2016, the President of Hubei Yunhong Deren Tourism Co., Ltd., a tourism project developer, since May 2016 and the President of Yunhong Group Holdings Co., Ltd., a company engaged in the business of solar power construction and solar photovoltaic power generation, since 2013. In addition, in 2013, Mr. Li founded China Hubei Yunhong Energy Group Co., Ltd., a Chinese nutrition company operating in China and abroad, and he currently serves as the Chairman of its board of directors.

 

Frank Cesario, Chief Executive Officer and Director; Acting Chief Financial Officer. Mr. Cesario first joined the Company in November 2017 as Chief Financial Officer. In December 2019 he was named President and Chief Executive Officer, and Director. He resigned as Chief Financial officer in June 2020 and President and Chief Executive Officer, and Director, in September 2020. During March 2021 he rejoined the Board as a Director. During January 2022 he was hired by the Company as Chief Executive Officer and Director. Upon the resignation of then Chief Financial Officer Jennifer Connerty during January 2022, Mr. Cesario also became the Acting Chief Financial Officer. Mr. Cesario brings 20 years of CFO experience at manufacturing entities. Prior to joining the Company, Mr. Cesario served in similar roles with Nanophase Technologies Corporation and ISCO International, Inc., then publicly traded global suppliers of advanced materials and telecommunications equipment, respectively, as well as Turf Ventures LLC, a privately held chemicals distributor. From September 2020 until January 2022, Mr. Cesario served as Chief Financial Officer of Radiac Abrasives, Inc., a privately held manufacturer. He began his career with KPMG Peat Marwick and then served in progressively responsible finance positions within Material Sciences Corporation and Outokumpu Copper, Inc. Mr. Cesario holds an MBA (Finance) from DePaul University and a B.S. (Accountancy) from the University of Illinois, and is a registered CPA in the State of Illinois.

 

Douglas Bosley, Director. Mr. Bosley has served as a director of the Company since January 2022 and is a founding partner of Witan Law Group and a member of the firm’s Corporate Transactional and Securities practice. Mr. Bosley represents businesses and entrepreneurs at all stages of growth from inception to exit. Mr. Bosley’s practice focuses on three general areas of financing transactions, mergers and acquisitions and general corporate matters. Mr. Bosley’s financing experience includes representing venture capital firms and venture-backed companies, mezzanine debt transactions, and a wide range of other types of financing and securities transactions, as well as general corporate matters including formation and start-ups; equity compensation; contracts such as licensing, joint ventures, representative agreements, and development and service level agreements; and corporate governance matters. Before founding Witan Law, Mr. Bosley was a partner at Bosley Till Neue & Talerico (BTNT), a law firm, where he headed the transactional and securities practices. Prior to BTNT, Mr. Bosley operated Bosley Business Law, which he founded after more than a decade of sophisticated corporate and securities transactional experience at some of the world’s largest and most reputable corporate law firms. Mr. Bosley also served as general counsel of a Sacramento-based venture capital and professional services firm. He is a frequent speaker on legal issues related to start-ups, mergers and acquisitions and venture capital transactions. Mr. Bosley is a graduate of the Duke University School of Law, graduating with high honors and earning Order of the Coif. He received his B.A. in Economics from California State University (Sacramento).

 

Gerald (J.D.) Roberts, Jr., Director. Mr. Roberts is Vice President of Strategy and Business Development at a Fortune 50 Corporation, having served in that capacity since 2018, and has served as a director of the Company since January 2022. In the previous 20 years, he held several senior roles at Aerojet Rocketdyne Holdings, Inc. and GenCorp/Aerojet. His career began in the aerospace and electronics industries in the United States and Australia, where he worked with companies including E-Systems, McDonnell Douglas, Northrop-Grumman, Gulfstream, Learjet and Hawker de Havilland. Mr. Roberts combined his credentials in engineering, finance and operations and his significant experience in strategic planning, organizational restructuring, and mergers, acquisitions, and divestitures to build value in international business opportunities. Mr. Roberts holds a Six Sigma greenbelt certification and has completed post-graduate coursework in Mergers and Acquisitions, leadership, strategic alliances, negotiation, innovation, and financial analysis. He received his MBA (Finance) from the University of California, Davis, and his B.S. in Mechanical Engineering from Virginia Tech.

 

Philip Wong, Director. Mr Wong has served as a director of the Company since January 2022 and is CEO of Shark AI Capital Corporation, an innovative business lending firm which he co-founded in 2020. Previously, he served as Chief Investment Officer of American Credit, Inc., as a Commercial Loan Officer at Applepie Capital, Inc., as Vice President / Senior Relationship Manager at Bank of the West / BNP Paribas, and as First Vice President / Senior Relationship Manager at Preferred Bank, among other roles in banking in business credit. Mr. Wong and has completed certifications in agile software development, software products management, healthcare analytics, and product management and marketing. He received his B.A. in Asian Studies from San Francisco State University.

 

22

 

Executive Officers Other Than Nominees

 

Jana Schwan. Ms. Schwan has been employed by the Company in progressively more responsible roles in operational, purchasing, and product development capacities since September 2002, and currently leads its Sales, Marketing and Business Development activities in addition to all Operations of the Company. Ms. Schwan was named Vice President of Operations in 2017 and Chief Operating Officer in 2020.

 

Jana Schwan is the daughter of John Schwan, who prior to his retirement from the Company served in several capacities, including as Chairman of the Board of Directors.

 

Except as disclosed in this Item 10 or Item 13 (Certain Relationships and Related Transactions, and Director Independence), there are no arrangements or understandings with major stockholders, customers, suppliers or others pursuant to which any of our directors or members of senior management were selected as such. In addition, there are no family relationships among our executive officers and directors.

 

Our future success depends, in significant part, on the continued service of certain key execute officers, managers, and others in various aspects of our business. We may not be able to find an appropriate replacement for any of our key personnel. Any loss or interruption of our key personnel’s service to the Company could adversely affect our ability to implement our business plan.

 

Corporate Governance

 

The business and affairs of the Company are managed under the direction of the Board of Directors in accordance with the Illinois Business Corporation Act and the Articles of Incorporation and By-laws of the Company, as amended. Members of the Board of Directors are kept informed of the Company’s business through discussions with the Chairman of the Board of Directors, the Chief Executive Officer, the President and other officers, by reviewing materials provided to them and by participating in meetings of the Board of Directors and its committees.

 

As of January 2022, the Board of Directors had five members. The Board has determined that each of Douglas Bosley, Gerald (J.D.) Roberts, Jr., and Philip Wong, presently directors of the Company, are independent based upon the application of the rules and standards of the NASDAQ Stock Market.

 

The Board of Directors met 8 times during 2022. Each of the Directors was present for at least 75% of such meetings.

 

Board Leadership Structure

 

Yubao Li is Chairman of the Board of Directors, Frank Cesario is Chief Executive Officer and Jana Schwan is Chief Operating Officer. Mr. Cesario and Ms. Schwan are responsible for senior management functions. Mr. Cesario reports into the Board of Directors. The Board of Directors believes that this combination and allocation of roles provides the most efficient and effective leadership model for the Company, providing perspective and direction with regard to business strategies and plans to both the Board and management. The Company has no bylaw or policy in place that mandates that an officer serve as Chairman of the Board. The Board of Directors periodically evaluates its leadership structure.

 

Mr. Wong has been designated as the lead independent director. Mr. Wong is responsible for (i) communicating regularly with the Chief Executive Officer and other officers of the Company on behalf of the Board of Directors, and particularly the independent members of the Board of Directors, and (ii) calling separate meetings of the independent directors of the Company. At any such meetings, only independent directors are present and the independent directors are free to discuss any aspect of the Company’s business and risk management without the influence of interested directors or management.

 

All members of the Company’s Audit, Compensation and Nominating and Governance Committees have been determined to be independent based on application of the rules and standards of the NASDAQ Stock Market.

 

23

 

Board Role in Risk Oversight

 

The Board of Directors plays an active role, as a whole and at the committee level, in overseeing management of the Company’s risks. The Board regularly reviews information regarding our credit, liquidity and operations, as well as the risks associated with each. The Audit Committee oversees management of financial risks through regular meetings with the Company’s independent registered public accounting firm and the Company’s Chief Executive Officer, President and Chief Financial Officer. The Company’s Compensation Committee evaluates and addresses risks relating to executive compensation, our incentive compensation plans and other compensatory arrangements. The Nominating and Governance Committee manages risks associated with the independence of the Board of Directors and potential conflicts of interest. While each committee is responsible for evaluating certain risks and overseeing the management of those risks, the entire Board of Directors is regularly informed through management and committee reports to the full Board about these and other operational risks.

 

Committees of the Board of Directors

 

The Board of Directors has standing Audit, Compensation and Nominating and Governance Committees.

 

Audit Committee

 

Since 2000, the Company has had a standing Audit Committee, which is presently composed of Mr. Wong (Chairman), Mr. Bosley and Mr. Roberts. Each of the members of the Audit Committee is independent based on the application of the rules and standards of the NASDAQ Stock Market and Rule 10a-3(b) under the Securities Exchange Act of 1934. Mr. Wong has been designated as, and is, the Company’s “Audit Committee Financial Expert” in accordance with Item 407(d)(5) of Regulation S-K and meets the requirements for an audit committee expert as set forth in that item. The Audit Committee has primary responsibility meetings with management and independent auditors to discuss the Company’s financial statements. The Company’s Board of Directors has adopted a written charter, as amended, for the Company’s Audit Committee, a copy of which has been posted and can be viewed on the Company’s Internet website at http://www.ctiindustries.com under the section entitled “Investor Relations.” In addition, the Audit Committee has adopted a complaint monitoring procedure to enable confidential and anonymous reporting to the Audit Committee of concerns regarding, among other things, questionable accounting or auditing matters. The Audit Committee has primary responsibility for:

 

Appointing, compensating, and retaining our registered independent public accounting firm;

 

Overseeing the work performed by any outside accounting firm;

 

Assisting the Board of Directors in fulfilling its responsibility by reviewing the financial reports provided by us to the SEC, our stockholders, or to the general public, as well as the Company’s internal financial and accounting controls; and

 

Recommending, establishing, and monitoring procedures designed to improve the quality and reliability of the disclosure of our financial condition and results of operations.

 

The Audit Committee met three times during 2022.

 

Compensation Committee

 

The Compensation Committee is composed of Mr. Roberts (Chairman), Mr. Bosley and Mr. Wong. The Board has determined that each of the members of the Compensation Committee is independent as defined in the listing standards for the NASDAQ Stock Market. The Compensation Committee reviews and acts on the Company’s executive compensation and employee benefit and retirement plans, including their establishment, modification and administration. It also recommends to the Board of Directors the compensation of the Chief Executive Officer and certain other executive officers. The Compensation Committee has a charter which has been posted and can be viewed on the Company’s Internet website at http://www.ctiindustries.com under the section entitled “Investor Relations.” The Compensation Committee met twice in 2022.

 

24

 

Nominating and Governance Committee

 

In 2005, the Company established a Nominating and Governance Committee. The Nominating and Governance Committee consists of Mr. Bosley (Chairman), Mr. Roberts and Mr. Wong. The Nominating and Governance Committee does not have a charter. The Board of Directors has determined that each of the members of the Nominating and Governance Committee is independent as defined in the listing standards for the NASDAQ Stock Market.

 

The Nominating and Governance Committee has not adopted a formal policy with regard to consideration of director candidates recommended by security holders. The Company believes that continuing service of qualified incumbent members of the Board of Directors promotes stability and continuity at the Board level, contributes to the Board’s ability to work as a collective body and provides the benefit of familiarity and insight into the Company’s affairs. Accordingly, the process of the Nominating and Governance Committee for identifying nominees reflects the Company’s practice of re-nominating incumbent directors who continue to satisfy the criteria for membership on the Board. For vacancies that are anticipated on the Board of Directors, the Nominating and Governance Committee intends to seek out and evaluate potential candidates from a variety of sources that may include recommendations by security holders, members of management, the Board of Directors, consultants and others. The minimum qualifications for potential candidates for the Board of Directors include demonstrated business experience, decision-making abilities, personal integrity and a good reputation.

 

The Board’s statement regarding diversity is below. This has become a larger factor in the Nominating Committee’s evaluation of potential candidates. While there is no formal policy for considering diversity when nominating a potential director, it is a consideration that is evaluated along with other qualifications of potential candidates, and broadly a goal of the Company. In light of the foregoing, it is believed that a formal, written policy and procedure with regard to consideration of director candidates recommended by security holders is not necessary in order for the Nominating and Governance Committee to perform its duties.

 

The Nominating Committee did not meet in 2022. All of the independent directors of the Board of Directors participated in the nominating process and, in separate session, voted in favor of recommending to the Board of Directors the nomination of each of the nominees for election as directors.

 

Board Diversity

 

The current Board has five directors, all male, two of whom are of Asian background and three Caucasian. The Board recently had two female directors who retired from the Board during January 2022. With only five directors, the Company has limited opportunity to maintain the breadth of diversity it seeks. The Company has made diversity a goal, particularly as it moved from a 100% Caucasian, 100% male Board of Directors at the beginning of 2020 to three Asian directors, two of whom female, later that year. The Company plans to continue to strive for broad representation on its Board of Directors.

 

25

 

Section 16(a) Beneficial Ownership Reporting Compliance

 

Section 16(a) of the Securities Exchange Act of 1934 requires the Company’s officers and directors, and persons who own more than ten percent of a registered class of the Company’s equity securities, to file reports of ownership and changes in ownership with the Securities and Exchange Commission and with the NASDAQ Stock Market. Officers, directors and greater than ten-percent shareholders are required by SEC regulation to furnish the Company with copies of all Section 16(a) forms they file.

 

Based solely on a review of such forms furnished to the Company, the Company believes that during calendar year 2022, all Section 16(a) filing requirements applicable to the officers, directors and ten-percent beneficial shareholders were satisfied.

 

Code of Ethics

 

The Company has adopted a code of ethics that applies to its senior executive and financial officers. The Company’s Code of Ethics seeks to promote (i) honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships, (ii) full, fair, accurate, timely and understandable disclosure of information to the Commission, (iii) compliance with applicable governmental laws, rules and regulations, (iv) prompt internal reporting of violations of the Code to predesignated persons, and (v) accountability for adherence to the Code. A copy of the Code of Ethics has been posted and may be viewed on the Company’s Internet website at http://www.ctiindustries.com under the heading “Investor Relations.” The Company will provide to any person without charge upon request a copy of the Code of Ethics. You may make such request by sending a written request to the Corporate Secretary at 22160 N. Pepper Road, Lake Barrington, Illinois 60010 and providing a return address.

 

Item No. 11 – Executive Compensation

 

The following table sets forth summary compensation information with respect to the Principal Executive Officer and each of the two other most highly compensated executive officers. These individuals, including the Principal Executive Officer, are collectively referred to in this proxy statement as the Named Executive Officers.

 

               Non-Equity         
           Option   Incentive Plan   All other     
Name/Title  Year   Salary   Awards   Compensation   compensation   Total 
           (1)   (2)   (3)     
                          
Frank Cesario   2022   $235,577   $102,500   $-   $-   $338,077 
Chief Executive Officer(4)   2021   $-   $-   $-   $1,500   $1,500 
                               
Jana M. Schwan   2022   $201,910   $43,000   $-   $9,500   $254,410 
Chief Operating Officer (5)   2021   $165,538   $-   $-   $9,500   $175,038 
                                                        
Jennifer M. Connerty   2022   $32,013   $-   $-   $-   $32,013 
Chief Financial Officer (6)   2021   $152,885   $-   $-   $-   $152,885 

 

SUMMARY COMPENSATION TABLE

 

(1) Reflects the compensation expense recognized in 2022 and 2021 for stock awards under ASC Topic 718 as reported in the Company’s audited financial statements.
(2) Amounts determined under the Company’s incentive compensation program.
(3) Amounts for include matching 401(k) contributions and insurance premiums
(4) Mr. Cesario rejoined the Company in January 2022 as Chief Executive Officer and Acting Chief Financial Officer.
(5) Ms. Schwan became Chief Operating Officer in 2020.
(6) Ms. Connerty became Chief Financial Officer in 2020. She resigned from the Company during January 2022.

 

26

 

Narrative Disclosure for Summary Compensation Table

 

Employment Agreements with Our Named Executive Officers

 

No employment agreements existed until January 2022, when Mr. Cesario entered into an employment agreement with the Company. That agreement includes a base salary of $250,000 per year. Mr. Cesario received an inducement grant of stock in the amount of 250,000 shares, 25,000 of which vested immediately, with the remaining shares scheduled to vest based upon the achievement of certain goals and objectives as set forth in the agreement. Mr. Cesario is eligible to receive a performance-based bonus of $300,000. In the event that Mr. Cesario is terminated without cause, he is eligible to receive twelve (12) months of salary in accordance with the agreement.

 

Information Relating to Cash Incentives

 

The Board of Directors previously had adopted an Incentive Compensation Plan providing for annual incentive compensation to be paid to executive and managerial employees of the Company. Under the Plan, designated Named Executive Officers and several other executive officers and managers may receive incentive compensation payments, determined on a quarterly and annual basis, based upon the income of the Company before provision for income tax or for incentive compensation if the net income exceeds a threshold amount of profit for any quarter of $100,000 and, for the year, of $250,000. The benefits under the Plan are divided into two Pools of compensation. Pool I (representing the largest pool of incentive compensation) covers senior executive officers and managers who participate in the pool of incentive compensation based upon a percentage allocation recommended by the Compensation Committee and determined by the Board of Directors each year. Pool II covers other executives and managers who are selected to participate in proportions determined by management. The Compensation Committee recommends the amount of the incentive compensation awards which, in the aggregate, may not exceed sixteen percent of the net income of the Company (before provision for income tax or incentive compensation under the Plan). Further, the amount of incentive compensation to any participant may not exceed the annual base compensation of the participant. The Compensation Committee believed such incentive compensation motivates participants to achieve strong profitability which is viewed as the most significant element of corporate performance, provides rewards for strong corporate performance and aligns the incentive with the interests of the shareholders. Incentive compensation participation levels are generally determined during the first quarter of each fiscal year.

 

In determining the executives who participate in the incentive compensation awards in Pool I each year, and the relative amount of the award to each participant, the Compensation Committee considers and takes into account (i) the position of the executive, (ii) the level of responsibility and authority of the executive, (iii) the performance of the executive, and (iv) the extent to which the executive is in a position to affect the financial results and profitability of the Company. The current Board of Directors is considering a revised incentive plan and terminating the plan described in this section. No replacement plan has yet been adopted, but the Board of Directors and Management have both indicated their desire to change this program.

 

Long-Term Equity Incentives

 

The Board of Directors adopted and approved a new incentive option plan in April 2018 which was submitted to, and approved by, our stockholders at the annual meeting of stockholders on June 8, 2018 (the “Plan”). This Plan updated and replaced the prior Stock Incentive Plan from 2009. Under the Plan, the Compensation Committee of the Board of Directors is authorized to issue incentive options, non-statutory options, restricted stock awards and stock grants to officers, directors, management personnel and consultants of the Company. The Board of Directors determined that no further options would be granted under the 2009 Incentive Stock Plan.

 

Stock and option grants under the Plan will be determined from time to time by the Compensation Committee in consultation with management. The actual grant for each executive is determined by taking into consideration (i) individual performance, (ii) corporate performance and (iii) prior grants to, or stock ownership of the Company by, the executive or director. Generally, stock options are granted with an exercise price equal to or greater than the closing price of the Company’s common stock on the NASDAQ Stock Market on the date of the grant.

 

No stock options or grants were awarded or issued during 2021.

 

During 2022, each of the three independent Directors was granted 5,000 shares of restricted stock that vest over 12 months.

 

Effective January 2022, and in accordance with the Employment Agreement of Chief Executive Officer Frank Cesario, a grant of restricted stock was made in the amount of 250,000 shares. 25,000 shares vested immediately, while the remaining 225,000 are subject to performance conditions as further detailed in the share grant. Specifically, the restrictions on the remaining 225,000 shares will lapse based on satisfaction of the following performance goals and objectives and continued employment through the date of meeting such targets:

 

● The restrictions on 56,250 shares of the award will lapse and the award will vest when the Company’s trailing-twelve-month EBITDA equals or exceeds $1 million at any time on or after January 1, 2022.

● The restrictions on 56,250 shares of the award will lapse and the award will vest in the event the Company’s common shares trade at or above $5/share for ten or more consecutive trading days.

● The restrictions on 56,250 shares of the award will lapse and the award will vestwhen the Company’s operating cash flow, calculated cumulatively from the date of employment, equals or exceeds $1.5 million. The Compensation Committee determined this condition was satisfied during February 2023.

● The restrictions on 56,250 shares of the award will lapse and the award will vest in the event the Company is able to refinance its current lender with a traditional lender on terms and conditions customary for such financing. On August 23, 2022, the Compensation Committee determined this condition had been satisfied with an amended agreement with the Company’s lender.

 

During 2022, the Compensation Committee awarded the Company’s Chief Operating Officer a grant of 100,000 shares of restricted stock. 20,000 of those shares vest over a 12 month period while the remaining shares vest 20,000 each based on the performance conditions above.

 

The Compensation Committee (as defined in the Plan) shall be responsible for determining when the conditions above have been satisfied. The Company records compensation expense with each vesting, and records a likelihood of vesting weighted analysis to the extent it has visibility to do so. Without such visibility, it considers such probability as de minimis until additional information is available.

 

27

 

Retirement Benefits

 

The Company maintains a 401(k) employee savings plan in which all salaried employees are eligible to participate. The plan is a tax qualified retirement plan.

 

Under the 401(k) Plan, employees may contribute up to 15% of their eligible compensation to the Plan and the Company will contribute a matching amount to the Plan each year. Participating employees may direct the investment of individual and company contributions into one or more of the investment options offered by the Plan. Under the terms of the Plan, the Company has made a matching contribution equal to 100% of employee contributions that do not exceed 1% of eligible compensation plus 50% of employee contributions between 1% and 5% of eligible compensation. During 2017, the Board of Directors determined to cease matching contributions under the 401(k) Plan for the balance of the year. No such matching contributions were made during 2020 or 2021.

 

OUTSTANDING EQUITY AWARDS

 

   Equity Awards
   Number of Securities Underlying    
   Unvested Performance Grants  Exercise 
Name  Exercisable  Unexercisable   Price ($) 
Frank J. Cesario  -   168,750   $- 
                          
Jana M. Schwan  -   60,000   $- 

 

EQUITY COMPENSATION PLAN INFORMATION

 

The following table sets forth the common stock of the Company authorized for issuance under the Company’s equity compensation plans as of December 31, 2022.

 

Plan Category  Number of securities to
be issued upon exercise
of outstanding options,
warrants and rights		   Weighted-average
exercise price of
outstanding options,
warrants and rights		   Number of securities
remaining available for
future issuance under
equity compensation plans		 
Equity compensation plans by security holders   400,000   $-    400,000 
                                
Equity compensation plans not approved by security holders   -    -    - 
                
Total   400,000   $-    400,000 

 

Payments Upon Termination or Change of Control

 

The employment agreement with Frank Cesario, effective January 2022, includes payment of twelve months salary upon termination except for cause as is defined by that agreement.

 

28

 

Director Compensation

 

The following table sets forth the compensation of directors of the Company during the year ended December 31, 2021:

 

DIRECTOR COMPENSATION

 

   Director’s   Stock   All other     
Name  Fees   Awards (1)   compensation   Total 
Yubao Li  $-   $-   $-   $- 
                     
Frank Cesario  $-   $-   $-   $- 
                                
Douglas Bosley  $12,000   $4,750   $-   $16,750 
                     
JD Roberts  $12,000   $4,750   $-   $16,750 
                     
Philip Wong  $12,000   $4,750   $-   $16,750 

 

  (1) Reflects the compensation expense recognized in 2022 for stock awards under ASC Topic 718 as reported in the Company’s audited financial statements.

 

Narrative Description of Director Compensation

 

Payments to non-employee directors were suspended during 2019, and restarted as of January 2022.

 

Agreements Between Third Parties and Directors

 

There are no agreements or arrangements by which any directors or nominees are to receive compensation or other payments from third parties in return for serving on the Board of Directors.

 

Item No. 12 – Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

 

The Board of Directors knows of no other matters to be presented for shareholder action at the Annual Meeting. On matters which may be raised at the Annual Meeting that are not covered by this Proxy Statement, the persons named in the proxy will have full discretionary authority to vote.

 

29

 

BENEFICIAL OWNERSHIP OF SHARES BY MANAGEMENT

AND SIGNIFICANT SHAREHOLDERS

 

The following table provides information concerning the beneficial ownership of the Company’s Common Stock by each director and nominee for director, certain executive officers, and by all directors and officers of the Company as a group as of December 31, 2022. In addition, the table provides information concerning the current beneficial owners, if any, known to the Company to hold more than 5 percent of the outstanding Common Stock of the Company.

 

The amounts and percentage of stock beneficially owned are reported based on regulations of the Securities and Exchange Commission (“SEC”) governing the determination of beneficial ownership of securities. Under the rules of the SEC, a person is deemed to be a “beneficial owner” of a security if that person has or shares “voting power,” which includes the power to dispose of or to direct the disposition of such security. A person is also deemed to be a beneficial owner of any securities of which that person has a right to acquire beneficial ownership within 60 days after December 31, 2022. Under these rules, more than one person may be deemed a beneficial owner of the same securities and a person may be deemed a beneficial owner of securities in which he has no economic interest. The percentage of Common Stock beneficially owned is based on 16,059,091 shares of Common Stock outstanding as of December 31, 2022.

 

  Shares of

Common Stock

   Shares of

Preferred Stock

   Percent of

Common

 
Name and Address of Beneficial Owner  Beneficially Owned   Beneficially Owned   Stock 
Yubao Li/Yunhong   7,100,000(1)   -    40%
Mr. Wang   1,700,000(2)   170,000    10%
Icy Melon   1,826,399    -    10%
Mitzners Consulting   1,564,691    -    9%
Frank J. Cesario   83,250    -    * 
Jana Schwan   45,725    -    * 
Douglas Bosley   5,000    -    * 
Gerald JD Roberts, Jr.   5,000    -    * 
Philip Wong   5,000    -    * 
All Current Directors and Executive Officers as a group   7,243,975    170,000    41%

 

(1)These shares are held by LF Investments Pte. Ltd., a Singapore private limited company controlled by Mr. Li.

 

(2)Represents 1,700,000 shares of common stock issuable upon conversion of 170,000 shares of Series B preferred

 

*Less than one percent

 

30

 

Item No. 13 – Certain Relationships and Related Transactions

 

As of December 2017, Mr. John H. Schwan was owed a total of $1.1 million, with additional accrued interest of $0.4 million, by the Company. As part of the December 2017 financing with PNC, Mr. Schwan executed a subordination agreement related to these amounts due him, as evidenced by a related note representing the amount owed to Mr. Schwan. During January 2019, Mr. Schwan and the Company agreed to an exchange of $0.6 million of his debt for approximately 181,000 shares of CTI common stock at the then market rate of $3.32 per share. As of December 31, 2022, the balance of Mr. Schwan’s note was approximately $1.3 million, including accrued interest. Mr. Schwan is the father of Jana Schwan.

 

Relationships and transactions in which the Company and its directors and executive officers or their immediate family members are participants or have conflicts of interest are reviewed and approved by the Audit Committee. While the Audit Committee has not adopted a written policy for the review and approval of related party transactions, in determining whether to approve or ratify any such transaction, the Audit Committee considers, in addition to such other factors it may deem appropriate in the circumstances, whether (i) the transaction is fair and reasonable to the Company, (ii) under all of the circumstances, the transaction is in, or not inconsistent with, the Company’s best interests, and (iii) the transaction will be on terms no less favorable to the Company than could have been obtained in an arms’ length transaction with an unrelated third party. The Audit Committee, in its discretion, may request information from any party to facilitate its consideration of matter. The Audit Committee does not allow a director to participate in any review, approval or ratification of any transaction if he or she, or his or her immediate family member, has a direct or indirect material interest in the transaction.

 

Item No. 14 – Principal Accountant Fees and Services

 

The following table sets forth the amount of fees billed by our independent registered public accounting firm, for professional services during the year ended December 31, 2021, and the combination of LJ Soldinger Associates LP and RBSM LLP for the year ended December 31, 2022:

 

   Dec. 31, 2022   Dec. 31, 2021 
Audit Fees (1)  $330,100   $254,000 
Other Audit Related Fees (2)   -    - 
All Other Fees (3)   6,000    - 
Total Fees  $336,100   $254,400 

 

(1) Includes the annual financial statement audit and limited quarterly reviews and expenses.

 

(2) Includes fees and expenses for other audit related activity.

 

(3) May represent tax services and other consulting services.

 

All audits, tax and other services to be performed for the Company must be pre-approved by the Audit Committee. The Audit Committee reviews the description of services and an estimate of the anticipated costs to perform those services. Services not previously approved cannot commence until such approval has been granted. Pre-approval is granted usually at regularly scheduled meetings. If unanticipated items arise between meetings of the Audit Committee, the Audit Committee has delegated approval authority to the Chairman of the Audit Committee, in which case the Chairman communicates such pre-approvals to the full Committee at its next meeting.

 

The Audit Committee of the Board of Directors reviews all relationships with its independent auditors, including the provision of non-audit services, which may relate to the independent registered public accounting firm’s independence.

 

31

 

PART IV

 

Item No. 15 – Exhibits and Financial Statement Schedules

 

(a)(1) The following documents are filed under pages F-1 through F-29 and are included as part of this Form 10-K:

 

REPORTS OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM F-1
CONSOLIDATED BALANCE SHEETS F-3
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) F-4
CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY F-5
CONSOLIDATED STATEMENTS OF CASH FLOWS F-6
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS F-7

 

(a)(2) All financial statement schedules are omitted because the information is inapplicable or presented in the notes to the financial statements, except for Schedule II – Valuation and qualifying accounts.

 

(a)(3) Exhibits required by Item 601 of Regulation S-K are incorporated herein by reference and are listed on the attached Exhibit Index.

 

32

 

Exhibit

Number

 Document
     
3.1   Restated Articles of Incorporation (Incorporated by reference to Exhibit A to Registrant’s Schedule 14A Definitive Proxy Statement filed April 29, 2015).
3.2   Amended and Restated By-Laws of Yunhong CTI, Ltd (Incorporated by reference to Exhibit 3.2, contained in Registrant’s Form 8-K filed on March 17, 2017).
3.3   Amended and Restated Certificate of Designation of Series A Convertible Preferred Stock (Incorporated by reference to Exhibit 3.1, contained in the Registrant’s form 8-K filed on February 19, 2020).
3.4   Articles of Amendment to the Registrant’s Articles of Incorporation (Incorporated by reference to Exhibit 3.1, contained in the Registrant’s form 8-K filed on March 16, 2020).
3.5   Certificate of Designations, Preferences and Rights of Series B Redeemable Convertible Preferred Stock, No Par Value (Incorporated by reference to Exhibit 3.1 contained in Registrant’s Form 8-K/A filed on May 5, 2021).
3.6   Certificate of Designations of Series C Convertible Preferred Stock (Incorporated by reference to Exhibit 3.1 contained in Registrant’s Form 8-K/A filed on May 5, 2021).
3.7   Certificate of Designations of Series D Convertible Preferred Stock (Incorporated by reference to Exhibit 3.1 contained in Registrant’s Form 8-K filed on December 7, 2021).
4.1   Form of Yunhong CTI, Ltd common stock certificate (Incorporated by reference to Exhibit 4.1 contained in Registrant’s Report on Form 10-K dated March 31, 2017).
10.1   Yunhong CTI, Ltd 2018 Stock Incentive Plan (Incorporated by Reference to Schedule A contained in Registrant’s 14A Definitive Proxy Statement, as filed with the Commission on April 30, 2018)
10.2   Revolving Credit, Term Loan, and Security Agreement dated December 14, 2017 (PNC Bank National Association)(Incorporated by reference to Exhibit 10.1, contained in Registrant’s Form 8-K filed on December 19, 2017).
10.3   Revolving Credit Note dated December 14, 2017 (PNC Bank National Association) (Incorporated by reference to Exhibit 10.2, contained in Registrant’s Form 8-K filed on December 19, 2017).
10.4   Term Note dated December 14, 2017 (PNC Bank National Association) (Incorporated by reference to Exhibit 10.3, contained in Registrant’s Form 8-K filed on December 19, 2017).
10.5   Promissory Note dated December 14, 2017 (PNC Bank National Association) (Incorporated by reference to Exhibit 10.4, contained in Registrant’s Form 8-K filed on December 19, 2017).
10.6   Real Property Mortgage dated December 14, 2017 (PNC Bank National Association) (Incorporated by reference to Exhibit 10.5, contained in Registrant’s Form 8-K filed on December 19, 2017).
10.7   Subordination Agreement dated December 14, 2017 (PNC Bank National Association) (Incorporated by reference to Exhibit 10.6, contained in Registrant’s Form 8-K filed on December 19, 2017).
10.8   Waiver and Amendment No. 1 to Revolving Credit, Term Loan and Security Agreement dated June 12, 2018 (PNC Bank National Association) (Incorporated by reference to Exhibit 10.1, contained in Registrant’s Form 8-K filed on June 12, 2018)
10.9   Consent and Amendment No. 2 to Revolving Credit, Term Loan and Security Agreement dated October 18, 2018 (PNC Bank National Association) (Incorporated by reference to Exhibit 10.1, contained in Registrant’s form 8-K filed on October 18, 2018)

 

33

 

10.10   Subscription Agreement among Registrant and John H. Schwan dated December 21, 2018 (Incorporated by reference to Exhibit 10.1, contained in Registrant’s form 8-K filed on January 17, 2019).
10.11   Settlement Agreement and Release dated January 21, 2019 (PNC Bank National Association) (Incorporated by reference to Exhibit 10.18, contained in Registrant’s form 10-K filed on April 16, 2019).
10.12   Amendment No.1 to Agreement among CTI, GLG, Page and H One dated January 21, 2019 (Incorporated by reference to Exhibit 10.19, contained in Registrant’s form 10-K filed on April 16, 2019).
10.13   Amendment No. 3 and Forbearance Agreement to Revolving Credit, Term Loan and Security Agreement dated March 4, 2019 (PNC Bank National Association) (Incorporated by reference to Exhibit 10.1, contained in Registrant’s form 8-K filed on March 8, 2019).
10.14   Amendment No. 4 and Forbearance Agreement dated October 18, 2019 (PNC Bank National Association) (Incorporated by reference to Exhibit 10.1, contained in Registrant’s form 8-K filed on October 24, 2019).
10.15   Stock Purchase Agreement, dated as of January 3, 2020 (Incorporated by reference to Exhibit 10.1, contain in Registrants form 8-K filed on January 3, 2020).
10.16   Limited Waiver, Consent, Amendment No. 5 and Forbearance Agreement (PNC Bank National Association) (Incorporated by reference to Exhibit 10.1, contained in the Registrant’s form 8-K filed on January 16, 2020).
10.17   Amendment No. 1 to Securities Purchase Agreement, dated as of February 24, 2020 (Incorporated by reference to Exhibit 10.1, contained in the Registrant’s form 8-K filed on February 26, 2020).
10.18   Amendment No.2 to Securities Purchase Agreement dated as of April 13, 2020 (Incorporated by reference to Exhibit 10.1, contained in Registrant’s form 8-K filed on April 17, 2020.
10.19   Stock Purchase Agreement (Incorporated by reference to Exhibit 10.1 contained in Registrant’s Form 8-K filed on November 25, 2020).
10.20   Securities Purchase Agreement (Incorporated by reference to Exhibit 10.1 contained in Registrant’s Form 8-K filed on January 15, 2021).
10.21   Purchase and Sale Agreement (Incorporated by reference to Exhibit 10.1 contained in Registrant’s Form 8-K filed on April 29, 2021).
10.22   Lease Agreement (Incorporated by reference to Exhibit 10.2 contained in Registrant’s Form 8-K filed on April 29, 2021).
10.23   Promissory Note (Incorporated by reference to Exhibit 10.3 contained in Registrant’s Form 8-K filed on April 29, 2021).
10.24   Stock Redemption Agreement (Incorporated by reference to Exhibit 10.1 contained in Registrant’s Form 8-K filed on August 5, 2021).
10.25   Loan and Security Agreement (Incorporated by reference to Exhibit 10.1 contained in Registrant’s Form 8-K filed on October 6, 2021).
10.26   Stock Purchase Agreement (Incorporated by reference to Exhibit 10.1 contained in Registrant’s Form 8-K filed on December 7, 2021).
10.27   Warrant (Incorporated by reference to Exhibit 10.2 contained in Registrant’s Form 8-K filed on December 7, 2021).
10.28   Employment Agreement (Offer Letter) between Frank Cesario and the Company dated December 29, 2021 (Incorporated by reference to Exhibit 10.1 contained in Registrant’s Report on Form 8-K filed on January 11, 2022).
10.29   Exclusive Distribution Agreement, dated as of January 28, 2023 (Incorporated by reference to Exhibit 99.1 contained in Registrant’s Form 8-K filed on February 2, 2023).
14.1   Code of Ethics (Incorporated by reference to Exhibit 14 contained in the Registrant’s Form 10-K/A Amendment No. 2, as filed with the Commission on October 13, 2004).
23.1   Consent of Independent Registered Public Accounting Firm, BF Borgers CPA PC.
23.2   Consent of Independent Registered Public Accounting Firm, RBSM LLP.
31.1   Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and rule 15d-14(a) of the Securities Exchange Act, as amended (filed herewith).
31.2   Certification of Chief Financial Officer pursuant to Rule 13a-14(a) and rule 15d-14(a) of the Securities Exchange Act, as amended (filed herewith).
32.1   Certification of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith).
101   Interactive Data Files, including the following materials from the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, formatted in XBRL: (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Operations, (iii) the Consolidated Statements of Cash Flows, and (iv) the Notes to Consolidated Financial Statements.
104   Cover Page Interactive Data File (embedded within the Inline XBRL and contained in Exhibit 101)

 

  (a) The Exhibits listed in subparagraph (a)(3) of this Item 15 are attached hereto unless incorporated by reference to a previous filing.
  (b) The Schedule listed in subparagraph (a)(2) of this Item 15 is attached hereto.

 

Item No. 16 – Summary

 

None.

 

34

 

SIGNATURES

 

In accordance with Section 13 or 15(d) of the Exchange Act the Registrant caused this report to be signed on its behalf by the undersigned thereunto duly authorized on April 12, 2023.

 

  Yunhong CTI, LTD
     
  By: /s/ Frank Cesario
   

Frank Cesario, Chief Executive Officer, Acting Chief

Financial Officer, Director

 

In accordance with the Exchange Act, this report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.

 

Signatures   Title   Date
         

/s/ Yubao Li

   Chairman of the Board of Directors   April 12, 2023
Yubao Li        
         

/s/ Douglas Bosley

   Director   April 12, 2023
Douglas Bosley        
         

/s/ Gerald (J.D.) Roberts, Jr.

   Director   April 12, 2023
Gerald (J.D.) Roberts, Jr.        
         

/s/ Philip Wong

   Director   April 12, 2023
Philip Wong        

 

35

 

Yunhong CTI, LTD and Subsidiaries

 

Consolidated Financial Statements

 

Years ended December 31, 2022 and 2021

 

Contents

 

Consolidated Financial Statements:  
Report of Independent Registered Public Accounting Firm (PCAOB ID 5041) F-1
Report of Independent Registered Public Accounting Firm (PCAOB ID 587) F-2
Consolidated Balance Sheets as of December 31, 2022 and 2021 F-3
Consolidated Statements of Comprehensive Income (Loss) for the years ended December 31, 2022 and 2021 F-4
Consolidated Statements of Stockholders’ Equity as of December 31, 2022 and 2021 F-5
Consolidated Statements of Cash Flows for the years ended December 31, 2022 and 2021 F-6
Notes to Consolidated Financial Statements for the years ended December 31, 2022 and 2021 F-7

 

Financial Statement Schedule:

 

All other schedules for which a provision is made in the applicable accounting regulation of the Securities and Exchange Commission are not required under the related instructions or are inapplicable and, therefore, have been omitted.

 

36

 

Report of Independent Registered Public Accounting Firm

 

To the shareholders and the board of directors of Yunhong CTI Ltd.

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheet of Yunhong CTI Ltd. (the “Company”) as of December 31, 2022, the related statement of operations, stockholders’ equity (deficit), and cash flows for the year then ended, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022, and the results of its operations and its cash flows for the year then ended, in conformity with accounting principles generally accepted in the United States.

 

Substantial Doubt about the Company’s Ability to Continue as a Going Concern

 

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 3 to the financial statements, the Company’s significant operating losses raise substantial doubt about its ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.

  

Critical Audit Matters

 

Critical audit matters are matters arising from the current period audit of the financial statements that were communicated or are required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved especially challenging, subjective, or complex judgments.

 

We determined that there are no critical audit matters.

 

/s BF Borgers CPA PC

BF Borgers CPA PC (PCAOB ID 5041)

 

We have served as the Company’s auditor since 2022

Lakewood, CO

April 12, 2023

 

F-1

 

Report of Independent Registered Public Accounting Firm

 

To the Stockholders and the Board of Directors of

Yunhong CTI Ltd. and Subsidiaries

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheet of Yunhong CTI Ltd. and Subsidiaries (the Company) as of December 31, 2021, the related consolidated statement of comprehensive income (loss), stockholders’ equity and cash flows for each of the year ended December 31, 2021, and the related notes (collectively referred to as the financial statement). We did not audit the December 31, 2021 financial statements of Flexo Universal S. de R.L. de C.V., a 99.82 percent owned subsidiary (Flexo) which the Company sold on October 28, 2021. The Company has reclassified operations related to Flexo as discontinued operations for the period from January 1, 2021 to October 28, 2021. Those statements were audited by other auditors whose report has been furnished to us, and our opinion, insofar as it relates to the amounts included for Flexo, is based solely on the report of the other auditors. In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021, and the results of its operations and its cash flow for the year then ended, in conformity with accounting principles generally accepted in the United States of America.

 

The Company’s Ability to Continue as a Going Concern

 

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 3 to the financial statements, the Company has suffered recurring losses from operations and will require additional capital to continue as a going concern. This raises substantial doubt about the Company’s ability to continue as a going concern. Management’s plans regarding these matters are also described in Note 3. The consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the outcome of this uncertainty.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

Critical Audit Matters

 

The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.

 

Inventories Valuation

 

Critical Audit Matter Description

 

The Company’s inventories, net of reserves totaled approximately $7,876,000 as of December 31, 2021. As described in Note 2 and Note 8 to the consolidated financial statements, inventories are valued at the lower of cost or net realizable value. On a periodic basis, the Company reviews its inventory levels for estimated obsolescence or unmarketable items, in reference to future demand requirements and the shelf life of the products. As of December 31, 2021, the Company had established a reserve for obsolescence, marketability or excess quantities with respect to inventory in the aggregate amount of $290,000.

 

Given the judgments made by management a high degree of subjective and complex auditor judgment was required to evaluate management’s estimates of the net realizable value of its inventory and reserves for excess and obsolete inventory.

 

How the Critical Audit Matter Was Addressed in the Audit

 

The primary procedures we performed to address this critical audit matter included the following:

 

●We reviewed and evaluated the appropriateness and consistency of management’s methods.
●We reviewed and evaluated the significant assumptions and tested the accuracy and completeness of the underlying data used in management’s inventory reserve calculation.
●We recalculated the reserve using management’s methodology and evaluated the methodology and the significant assumptions for reasonableness.

 

/s/ RBSM LLP  
   
We have served as the Company’s auditor since 2019.  
   
New York, NY  

April 14, 2022

 

F-2

 

Yunhong CTI, Ltd

Consolidated Balance Sheets

 

           
  

December 31,

2022

  

December 31,

2021

 
ASSETS          
Current assets:          
Cash and cash equivalents  $146,000   $66,000 
Accounts receivable, net   1,618,000    3,443,000 
Inventories   8,325,000    7,876,000 
Prepaid expenses   389,000    625,000 
Other current assets   -    464,000 
           
Total current assets   10,478,000    12,474,000 
           
Property, plant and equipment:          
Machinery and equipment   17,723,000    17,470,000 
Office furniture and equipment   2,084,000    2,076,000 
Intellectual property   783,000    783,000 
Leasehold improvements   39,000    23,000 
Fixtures and equipment at customer locations   519,000    519,000 
Projects under construction   108,000    223,000 
Property, plant and equipment, gross   21,256,000    21,094,000 
Less : accumulated depreciation and amortization   (20,334,000)   (19,951,000)
           
Total property, plant and equipment, net   922,000    1,143,000 
           
Other assets:          
Operating lease right-of-use   3,882,000    3,530,000 
Other assets   -    135,000 
           
Total other assets   3,882,000    3,665,000 
           
TOTAL ASSETS   15,282,000    17,282,000 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY          
Current liabilities:          
           
Trade payables  $1,313,000   $2,132,000 
Line of credit   2,878,000    5,003,000 
Notes payable - current portion   289,000    726,000 
Notes payable - officers, subordinated   -    1,193,000 
Operating lease liabilities   518,000    670,000 
Accrued liabilities   2,480,000    647,000 
Current liabilities of discontinued operations   -    - 
           
Total current liabilities   7,478,000    10,371,000 
           
Long-term liabilities:          
Notes payable – net of current portion   427,000    - 
Notes payable - officers, subordinated   1,267,000    - 
Operating lease liabilities   3,364,000    2,860,000 
           
Total long-term liabilities   5,058,000    2,860,000 
           
TOTAL LIABILITIES   12,536,000    13,231,000 
           
Equity:          
Yunhong CTI, Ltd stockholders’ equity:          
Series A Preferred Stock — no par value, 3,000,000 shares authorized, none and 500,000 shares issued and outstanding at December 31, 2022 and 2021 respectively (liquidation preference - $5.0 million as of December 31, 2021)   -    3,155,000 
Series B Preferred Stock — no par value, 170,000 shares authorized, issued and outstanding at December 31, 2022 and 2021 respectively (liquidation preference - $1.7 million as of December 31, 2022)   1,851,000    1,715,000 
Series C Preferred Stock — no par value, none and 170,000 shares authorized, issued and outstanding at December 31, 2022 and 2021 respectively   -    1,630,000 
Series D Preferred Stock — no par value, none and 170,000 shares authorized, issued and outstanding at December 31, 2022 and 2021 respectively   -    1,512,000 
Common stock - no par value, 50,000,000 shares authorized, 16,102,749 and 5,930,408 shares issued and 16,059,991 and 5,886,750 shares outstanding at December 31, 2022 and December 31, 2021 respectively   21,283,000    14,538,000 
Paid-in-capital   3,895,000    4,317,000 
Accumulated deficit   (24,122,000)   (22,655,000)
Less: Treasury stock, 43,658 shares   (161,000)   (161,000)
           
Total Yunhong CTI, Ltd Stockholders’ Equity   2,746,000    4,051,000 
           
Total Stockholders’ Equity   2,746,000    4,051,000 
           
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY  $15,282,000   $17,282,000 

 

See accompanying notes to consolidated financial statements

 

F-3

 

Yunhong CTI, Ltd

Consolidated Statements of Operations and Comprehensive Income (Loss)

 

           
  

For the Twelve Months Ended

December 31,

 
   2022   2021 
         
Net Sales  $18,048,000   $24,086,000 
           
Cost of Sales   14,910,000    20,322,000 
           
Gross profit   3,138,000    3,764,000 
           
Operating expenses:          
General and administrative   3,720,000    3,815,000 
Selling   136,000    132,000 
Advertising and marketing   402,000    323,000 
           
Total operating expenses   4,258,000    4,270,000 
           
Loss from operations   (1,120,000)   (506,000)
           
Other (expense) income:          
Interest expense   (450,000)   (564,000)
Gain on Sale and Leaseback Transaction   -    3,357,000 
Reclassification of Cumulative Foreign Currency Loss   -    (5,885,000)
Loss on Sale of Subsidiary   -    (4,325,000)
Other income/(expense)   103,000    195,000 
           
Total other expense, net   (347,000)   (7,222,000)
           
Loss from continuing operations before taxes   (1,467,000)   (7,728,000)
           
Income tax expense   -    - 
           
Loss from continuing operations   (1,467,000)   (7,728,000)
           
Income (Loss) from discontinued operations , net of tax   -    174,000 
           
Net Loss  $(1,467,000)  $(7,554,000)
           
Less: Net loss attributable to noncontrolling interest   -    (718,000)
           
Net loss attributable to Yunhong CTI, Ltd  $(1,467,000)  $(8,272,000)
           
Other Comprehensive Income (Loss)          
Foreign currency adjustment   -    (388,000)
Reclassification of foreign currency adjustment to earnings   -    6,273,000 
Comprehensive loss  $(1,467,000)  $(1,669,000)
           
Deemed dividends on preferred stock and amortization of beneficial conversion feature  $(584,000)  $(3,573,000)
           
Net Loss Attributable to Yunhong CTI Ltd Common Shareholders  $(2,051,000)  $(11,845,000)
           
Basic income (loss) per common share          
Continuing operations  $(0.22)  $(2.04)
Discontinued operations   -    0.03 
Basic income (loss) per common share  $(0.22)  $(2.01)
           
Diluted income (loss) per common share          
Continuing operations  $(0.22)  $(2.04)
Discontinued operations   -    0.03)
Diluted income (loss) per common share  $(0.22)  $(2.01)
           
Weighted average number of shares and equivalent shares of common stock outstanding:          
Basic   9,301,888    5,878,887 
           
Diluted   9,301,888    5,878,887 

 

See accompanying notes to consolidated financial statements

 

F-4

 

Yunhong CTI, Ltd

Consolidated Statements of Stockholders’ Equity

 

   Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Earnings   Loss   Shares   Amount   Interest   TOTAL 
   Yunhong CTI, Ltd         
   Series A   Series B   Series C   Series D          

Accumulated

  

Accumulated

Other

   Less         
   Preferred Stock   Preferred Stock   Preferred Stock   Preferred Stock   Common Stock   Paid-in   (Deficit)   Comprehensive   Treasury Stock   Noncontrolling     
   Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Earnings   Loss   Shares   Amount   Interest   TOTAL 
                                                                     
Balance December 31, 2020   500,000   $2,754,583    -   $-    -   $-    -          5,827,304   $14,537,828   $5,041,511   $(14,382,327)  $(5,885,112)   (43,658)  $(160,784)  $(718,212)   1,187,487 
                                                                                      
Series D Convertible Preferred Stock Issuance                                 170,000    1,500,000                             -     -          1,500,000 
Series C Convertible Preferred Stock Issuance                       170,000    1,500,000                                       -     -          1,500,000 
Series B Convertible Preferred Stock Modification             170,000    1,612,707                                                 -     -          1,612,707 
Convertible Preferred Stock Issuance - conversion of debt                                                                    -     -          - 
Common stock issued for warrants exercised - cashless                                           103,104                        -     -            
BCF on Series C Preferred Stock                                                     1,500,000              -     -          1,500,000 
Deemed Dividend on BCF of Series C Preferred Stock                                                     (1,500,000)             -     -          (1,500,000)
Accrued Deemed Dividend - Series A Preferred Stock        400,417         -         -                        (400,417)             -     -          - 
Accrued Deemed Dividend - Series B Preferred Stock                  102,293                                  (135,904)             -     -          (33,611)
Accrued Deemed Dividend - Series C Preferred Stock                            130,000                        (130,000)             -     -          - 
Accrued Deemed Dividend - Series D Preferred Stock                                      12,000              (12,000)             -     -          - 
Accretion of Series B Preferred Stock                                                     (46,190)             -     -          (46,190)
Completion of HFS                                                                    -     -          - 
Net Income (Loss)                                                          (8,272,000)        -     -     718,000    (7,554,000)
Foreign Currency Translation                                                172         (673)   5,885,112    (342)   (216)   (305)   5,885,124 
Balance December 31, 2021   500,000   $3,155,000    170,000   $1,715,000    170,000   $1,630,000    170,000   $1,512,000    5,930,408   $14,538,000   $4,317,000   $(22,655,000)  $-    (44,000)  $(161,000)  $-    4,051,000 

 

   Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Earnings   Shares   Amount   TOTAL 
   Yunhong CTI, Ltd     
   Series A   Series B   Series C    Series D                Accumulated   Less     
  

Preferred Stock

  

Preferred Stock

  

Preferred Stock

  

Preferred Stock

   Common Stock   Paid-in   (Deficit)   Treasury Stock     
   Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Earnings   Shares   Amount   TOTAL 
                                                             
Balance December 31, 2021   500,000   $3,155,000    170,000   $1,715,000    170,000   $1,630,000    170,000   $1,512,000    5,930,408   $14,538,000   $4,317,000   $(22,655,000)   (44,000)  $(161,000)   4,051,000 
                                                                            
Accrued Deemed Dividend - Series A Preferred Stock        266,666                                            (266,666)             -     - 
Conversion - Series A Preferred Stock   (500,000)   (3,421,666)                                 6,278,990    3,421,666              -     -       
Accrued Deemed Dividend - Series B Preferred Stock                  136,000                                  (136,000)             -     - 
Accrued Deemed Dividend - Series C Preferred Stock                            90,667                        (90,667)             -     - 
Conversion - Series C Preferred Stock                       (170,000)   (1,720,667)             1,985,702    1,720,667              -     -       
Accrued Deemed Dividend - Series D Preferred Stock                                      90,667              (90,667)             -     - 
Conversion - Series D Preferred Stock                                 (170,000)   (1,602,667)   1,826,399    1,602,667                   -       
Stock Issuance                                           81,250                             - 
Equity Compensation Charge                                                     162,000              -     162,000 
Net Income (Loss)                                                          (1,467,000)       -     (1,467,000)
Balance December 31, 2022   -   $-    170,000   $1,851,000    -   $-    -   $-    16,102,749   $21,283,000   $3,895,000   $(24,122,000)   (44,000)  $(161,000)   2,746,000 

 

See accompanying notes to consolidated financial statements

 

F-5

 

Yunhong CTI, Ltd

Consolidated Statements of Cash Flows

 

   2022   2021 
   For the Year Ended December 31, 
   2022   2021 
         
Cash flows from operating activities:          
Net loss  $(1,467,000)  $(7,554,000)
Adjustments to reconcile net loss to net cash provided by (used in) operating activites          
Depreciation and amortization   383,000    462,000 
Equity compensation charge   162,000    - 
Amortization of ROU asset   -    501,000 
Realized currency translation gain   -    (92,000)
Gain on sale of building   -    (3,357,000)
Provision for losses on accounts receivable   -    40,000 
Impairment of Note Receivable   -    95,000 
Deconsolidation of disposed entities   -    10,015,000 
Change in assets and liabilities:          
Accounts receivable   1,825,000    (1,673,000)
Inventories   (449,000)   (604,000)
Prepaid expenses and other assets   836,000    132,000 
Change in ROU liability   -    (501,000)
Trade payables   (819,000)   (1,173,000)
Accrued liabilities   1,897,000    (1,000)
           
Net cash provided by (used in) operating activities   2,368,000    (3,710,000)
           
Cash flows from investing activities:          
Purchases of property, plant and equipment   (163,000)   (122,000)
Proceeds from Sale of building   -    3,500,000 
           
Net cash (used in) provided by investing activities   (163,000)   3,378,000 
           
Cash flows from financing activities:          
Repayment of debt and revolving line of credit   (2,125,000)   (8,284,000)
Proceeds from issuance of preferred stock   -    3,000,000 
Cash paid for deferred financing fees   -    (85,000)
Proceeds from issuance of long-term debt and revolving line of credit   -    5,995,000 
           
Net cash (used in) provided by financing activities   (2,125,000)   626,000 
           
Effect of exchange rate changes on cash   -    (550,000)
           
Net increase (decrease) in cash and cash equivalents   80,000    (256,000)
           
Cash and cash equivalents at beginning of year   66,000    322,000 
           
Cash and cash equivalents at end of year  $146,000   $66,000 
The cash flows related to discontinued operations have not been segregated, and are included in the Consolidated Statements of Cash Flows. The cash and equivalents amounts presented above differ from cash and equivalents in the Consolidated Balance Sheets due to cash included in “Current assets of discontinued operations.”          
           
Supplemental disclosure of cash flow information:          
Cash payments for interest  $375,000   $491,000 
Accrued dividend and accretion on Preferred Stock  $584,000   $536,000 
Lease right-of-use assets and lease liability  $747,000   $- 
Conversion of Series A, C and D Preferred Stock  $6,745,000   $- 
Issuance of Series C and D Preferred offerings  $-   $3,000,000 
Cash receipts for tax refund  $202,000   $206,000 
Amortization of beneficial conversion feature and deemed dividend on Series C and D Preferred stock  $-   $2,990,000 

 

See accompanying notes to consolidated financial statements

 

F-6

 

Notes to Consolidated Financial Statements of Yunhong CTI Ltd.

Years Ended December 31, 2022 and 2021

 

1. Nature of Business

 

Nature of Operations

 

Yunhong CTI Ltd. (formerly CTI Industries Corporation), its former subsidiaries - United Kingdom subsidiary (CTI Balloons Limited), Mexican subsidiary (Flexo Universal, S. de R.L. de C.V.), and German subsidiary (CTI Europe GmbH); as well as current subsidiary CTI Supply, Inc. (collectively, the “Company”) (i) design, manufacture and distribute metalized and latex balloon products throughout the world and (ii) operate systems for the production, lamination, coating and printing of films used for food packaging and other commercial uses and for conversion of films to flexible packaging containers and other products. As discussed in Note 19 Discontinued Operations, effective in 2019, the Company determined that it was exiting CTI Balloons Limited and CTI Europe, and during 2021 sold its interest in Flexo Universal. Accordingly, the operations of these entities are classified as discontinued operations in these financial statements.

 

2. Summary of Significant Accounting Policies

 

Principles of Consolidation

 

The consolidated financial statements include the accounts of Yunhong CTI Ltd., its wholly owned subsidiary CTI Supply, Inc. and former wholly owned subsidiary CTI Balloon Ltd and its former majority owned subsidiaries, Flexo Universal and CTI Europe. All significant intercompany accounts and transactions have been eliminated upon consolidation. As discussed in Note 21 Discontinued Operations, effective in 2019, the Company determined that it was exiting CTI Balloons Limited and CTI Europe, and during 2021 sold its interest in Flexo Universal. Accordingly, the operations of these entities are classified as discontinued operations in these financial statements.

 

Variable Interest Entities

 

The determination of whether or not to consolidate a variable interest entity under U.S. GAAP requires a significant amount of judgment concerning the degree of control over an entity by its holders of variable interest. To make these judgments, management has conducted an analysis of the relationship of the holders of variable interest to each other, the design of the entity, the expected operations of the entity, which holder of variable interests is most “closely associated” to the entity and which holder of variable interests is the primary beneficiary required to consolidate the entity. Upon the occurrence of certain events, management reviews and reconsiders its previous conclusion regarding the status of an entity as a variable interest entity.

 

Foreign Currency Translation

 

The financial statements of foreign subsidiaries were translated into U.S. dollars using the exchange rate at each balance sheet date for assets and liabilities, the historical exchange rate for stockholders’ equity, and a weighted average exchange rate for each period for revenues and expenses. Translation adjustments were recorded in accumulated other comprehensive income (loss) as the local currencies of the subsidiaries are the functional currencies. Foreign currency transaction gains and losses were recognized in the period incurred and are included in the consolidated statements of operations. This issue became moot with the elimination of all foreign subsidiaries between 2019-2021.

 

Use of Estimates

 

In preparing financial statements in conformity with accounting principles generally accepted in the United States of America, management makes estimates and assumptions that affect the amounts reported of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period in the financial statements and accompanying notes. Actual results may differ from those estimates. The Company’s significant estimates include valuation allowances for doubtful accounts, inventory valuation, deferred tax assets, goodwill and intangible asset valuation, leasehold assets and liabilities, Preferred Stock deemed dividends and beneficial conversion feature values, and assumptions used as inputs in the Black-Scholes option-pricing model.

 

Cash and Cash Equivalents

 

Cash and cash equivalents include cash on hand, demand deposits and short-term investments with original maturities of three months or less.

 

Accounts Receivable

 

Trade receivables are carried at original invoice amount less an estimate for doubtful receivables based on a review of all outstanding amounts on a monthly basis. Management determines the allowance for doubtful accounts by identifying troubled accounts, evaluating the individual customer receivables through consideration of the customer’s financial condition, credit history and current economic conditions and use of historical experience applied to an aging of accounts. A trade receivable is considered to be past due if any portion of the receivable balance is outstanding for a period over the customer’s normal terms. Trade receivables are written off when deemed uncollectible. Recoveries of trade receivables previously written off are recorded when received.

 

Inventories

 

Inventories are stated at the lower of cost or net realizable value. Cost is determined using standard costs which approximates costing determined on a first-in, first-out basis, to reflect the actual cost of production of inventories.

 

Production costs of work in process and finished goods include material, labor and overhead. Inventory is not recorded in excess of net realizable value.

 

F-7

 

Property, Plant and Equipment

 

Property and equipment are stated at cost. Expenditures for maintenance and repairs are charged to operations as incurred. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets. Leasehold improvements are amortized on a straight-line method over the lesser of the estimated useful life or the lease term. The estimated useful lives range as follows:

 

    (in years) 
Building   25-30 
Machinery and equipment   3-15 
Projects that prolong the life and increase efficiency of machinery   3-5 
Light Machinery   5-10 
Heavy Machinery   10-15 
Office furniture and equipment   5-8 
Intellectual Property   9-15 
Leasehold improvements   5-8 
Furniture and equipment at customer locations   1-3 

 

Light machinery consists of forklifts, scissor lifts, and other warehouse machinery. Heavy machinery consists of production equipment including laminating, printing and converting equipment. Projects in process represent those costs capitalized in connection with construction of new assets and/or improvements to existing assets including a factor for interest on funds committed to projects in process of $108,000 and $220,000 for the years ended December 31, 2022 and 2021, respectively. Upon completion, these costs are reclassified to the appropriate asset class.

 

Stock-Based Compensation

 

The Company has stock-based incentive plans which may grant stock option, restricted stock and unrestricted stock awards. The Company recognizes stock-based compensation expense based on the grant date fair value of the award and the related vesting terms. The fair value of stock-based awards is determined using the Black-Scholes model, which incorporates assumptions regarding the risk-free interest rate, expected volatility, expected option life, and dividend yield. See Note 14 for additional information.

 

Fair Value Measurements

 

Current professional accounting guidance applies to all assets and liabilities that are being measured and reported on a fair value basis. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date in the principal or most advantageous market. The requirements prescribe a fair value hierarchy that has three levels of inputs, both observable and unobservable, with use of the lowest possible level of input to determine fair value. A Level 1 input includes a quoted market price in an active market or the price of an identical asset or liability. Level 2 inputs are market data other than Level 1 inputs that are observable either directly or indirectly including quoted market prices for similar assets or liabilities, quoted market prices in an inactive market, and other observable information that can be corroborated by market data. Level 3 inputs are unobservable and corroborated by little or no market data.

 

The carrying value amounts of the Company’s cash and cash equivalents, accounts and notes receivable, accounts payable and other current liabilities are reasonable estimates of their fair values due to the short-term nature of these instruments. The fair value of business segments (as needed for purposes of determining indications of impairment to the carrying value of goodwill) is determined using an average of valuations based on market multiples and discounted cash flows, and consideration of our market capitalization. See Note 5 for further discussion.

 

Valuation of Long Lived Assets

 

The Company evaluates whether events or circumstances have occurred which indicate that the carrying amounts of long-lived assets (principally property, plant and equipment) may be impaired or not recoverable. The significant factors that are considered that could trigger an impairment review include: changes in business strategy, market conditions, or the manner of use of an asset; underperformance relative to historical or expected future operating results; and negative industry or economic trends. In evaluating an asset for possible impairment, management estimates that asset’s future undiscounted cash flows and appraised values to measure whether the asset is recoverable. The Company measures the impairment based on the projected discounted cash flows of the asset over its remaining life.

 

Deferred Financing Costs

 

Deferred financing costs are amortized over the term of the loan. Upon a refinancing, existing unamortized deferred financing costs are expensed.

 

F-8

 

Income Taxes

 

The Company accounts for income taxes using the liability method. As such, deferred income taxes reflect the net tax effects of temporary differences between carrying amounts of assets and liabilities for financial reporting purposes and the amount used for income tax purposes. Realization of deferred tax assets is dependent upon future earnings, the timing and amount of which are uncertain.

 

Deferred tax assets and liabilities are measured using enacted tax rates expected to be in effect when the anticipated reversal of these differences is scheduled to occur. Deferred tax assets are reduced by a valuation allowance when management cannot determine, in its opinion, that it is more likely than not that the Company will recover that recorded value of the deferred tax asset. The Company is subject to U.S. Federal, state and local taxes as well as foreign taxes in Mexico (through October 2021). U.S. income tax expense and foreign withholding taxes are provided on remittances of foreign earnings and on unremitted foreign earnings that are not indefinitely reinvested.

 

We utilize a two step approach to recognize and measure uncertain tax positions. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not the position will be sustained upon tax authority examination, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon ultimate settlement. See Note 10 for further discussion.

 

Revenue Recognition

 

On January 1, 2018, we adopted Accounting Standards Codification (ASC) Topic 606, Revenue from Contracts with Customers using the modified retrospective method. The adoption of ASC 606 did not have a material impact on our consolidated financial position or results of operations, as our revenue arrangements generally consist of a single performance obligation to transfer promised goods at a fixed price.

 

Net sales include revenues from sales of products and shipping and handling charges, net of estimates for product returns. Revenue is measured at the amount of consideration the Company expects to receive in exchange for the transferred products. Revenue is recognized at the point in time when we transfer the promised products to the customer and the customer obtains control over the products. The Company recognizes revenue for shipping and handling charges at the time the goods are shipped to the customer, and the costs of outbound freight are included in cost of sales, as we have elected the practical expedient included in ASC 606. In most cases, the Company has a single product delivery performance obligation. Accrued product returns are estimated based on historical data and evaluation of current information.

 

The Company provides for product returns based on historical return rates. While we incur costs for sales commissions to our sales employees and outside agents, we recognize commission costs concurrent with the related revenue, as the amortization period is less than one year and we have elected the practical expedient included in ASC 606. We do not incur incremental costs to obtain contracts with our customers. Our product warranties are assurance-type warranties, which promise the customer that the products are as specified in the contract. Therefore, the product warranties are not a separate performance obligation and are accounted for as described herein. Sales taxes assessed by governmental authorities are accounted for on a net basis and are excluded from net sales.

 

A disaggregation of product net sales is presented in Note 16.

 

Research and Development

 

The Company conducts product development and research activities which include (i) creative product development and (ii) engineering. During the years ended December 31, 2022 and 2021, research and development activities totaled approximately $200,000 and $206,000, respectively.

 

Advertising Costs

 

The Company expenses advertising costs as incurred.

 

Note 3 – Liquidity and Going Concern

 

The Company’s financial statements are prepared using account principles generally accepted in the United States (“U.S. GAAP”) applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has a cumulative net loss from inception to December 31, 2022 of approximately $24 million. The accompanying financial statements for the year ended December 31, 2022 have been prepared assuming the Company will continue as a going concern. The Company’s cash resources may be insufficient to meet its anticipated needs during the next twelve months. The Company may require additional funding on acceptable terms to support it is planned future operations. Management’s plans include executing on its business plan and raising external funds to the extent needed. These factors are indicators that there is substantial doubt about the ability to continue as a going concern for one year from the issuance of the accompanying consolidated financial statements. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 

The Company’s primary sources of liquidity have traditionally been comprised of cash and cash equivalents as well as availability under a Credit Agreement. Until September 30, 2021, that Credit Agreement was with PNC (see Note 9), which began in December 2017 as an $18 million revolving credit facility and a $6 million term loan. As noted in Note 9, we encountered a series of challenges in meeting conditions of that agreement, which added to liquidity issues and raised an issue regarding our ability to continue as a going concern during that period.

 

F-9

 

During September 2021, we entered into a new credit agreement with Line Financial, using those proceeds and the proceeds from multiple preferred stock issuances and the sale of preferred stock and the sale / leaseback transaction of our Lake Barrington, IL property (below) to fully repay PNC. The new agreement with Line Financial includes a revolving credit facility for up to $6 million and a term loan of $0.7 million, all supported by the majority of our assets. We also made structural changes to our business, removing the cash required to support subsidiaries that are no longer part of our group and other operating improvements.

 

In January 2021 we entered into an agreement with a related party, LF International Pte. Ltd. which is controlled by Company director, Chairman, President and Chief Executive Officer, Mr. Yubao Li, to purchase shares of Series C Preferred stock. We issued 170,000 shares of Series C Preferred for an aggregate purchase price of $1,500,000. The Series C Preferred have an initial stated value of $10.00 per share and liquidation preference over common stock.

 

On April 23, 2021, the Company entered into a Purchase and Sale Agreement (“PSA”) with an unaffiliated purchaser (the “Purchaser”) pursuant to which the Company sold its facility in Lake Barrington, Illinois (the “Lake Barrington Facility”), in which our headquarters office, production and warehouse space are located, to the Purchaser. The sale price for the Lake Barrington Facility was $3,500,000, consisting of $2,000,000 in cash and a promissory note with a principal amount of $1,500,000, due and payable on May 3, 2021 (the “Purchaser Promissory Note”). As part of its agreements with PNC, the Company agreed that the full $2,000,000 in cash proceeds from the sale of the Lake Barrington Facility would be applied to repay the $2,000,000 term loan owed to PNC pursuant to the Loan Agreement. The Company further agreed that $1,500,000 in proceeds from the Purchaser Promissory Note was applied to amounts due and owing to PNC under revolving credit advances made pursuant to the Loan Agreement (the “Revolving Loans”).

 

Concurrently with the closing under the PSA, the Company and the Purchaser entered into a lease agreement pursuant to which the Company agreed to lease the Lake Barrington Facility from the Purchaser for a period of ten years. The annual base rent commences at $500,000 for the first year of the term and escalates annually to $652,386 during the last year of the term of the lease.

 

In June 2021, the Company received $1.5 million from a third party as an advance on a proposed sale of Series D Redeemable Convertible Preferred Stock. As of December 1, 2021, the terms of the arrangement were finalized and this investment was reclassified into equity.

 

We believe we have been in compliance with our new credit facility since that time. As of December 31, 2022 we have drawn approximately $2.9 million of the maximum $6.0 million revolving line of credit, which is available subject to the value of receivables and inventory that support the line. Through December 31, 2022, the Company has received approximately $160,000 in Employee Retention Tax Credits (“ERTC”) from the United States Government related to claims that were filed during 2021. $123,000 is listed as General and Administrative, while the remainder is in Other Income. During October 2022 we had outstanding $1.2 million of additional ERTC claims that had not been processed. We factored those claims with a third party for $0.9 million. To the extent any portion of those claims are ultimately denied, we must refund a pro-rated amount of that $0.9 million. This is treated as deferred income on the balance sheet until such time as the original claims are processed. During January 2023, approximately $0.8 million of these claims were processed and paid, which was forwarded to the third party. At that time, we recognize approximately $0.6 million of the related deferred income.

 

F-10

 

4. New Accounting Pronouncements

 

Recent Accounting Pronouncements

 

Credit Loss

 

In June 2016, the FASB issued authoritative guidance to replace the incurred loss impairment methodology under current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. For public entities, the guidance is effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years, which for the Company was the first quarter of fiscal 2021. The adoption did not have a material impact on its consolidated financial statements.

 

Income Taxes

 

In December 2019, the FASB issued authoritative guidance that simplifies the accounting for income taxes as part of the overall initiative to reduce complexity in accounting standards. Amendments include removal of certain exceptions to the general principles of Accounting Standards Codification 740, Income Taxes. The amendments also include simplification in several other areas, such as recognition of deferred tax assets on step-up in tax basis in goodwill and accounting for franchise tax that is partially based on income. For public entities, the guidance is effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years, which for the Company was the first quarter of fiscal 2021. The adoption did not have a material impact on its consolidated financial statements.

 

5. Fair Value Disclosures

 

U.S. GAAP clarifies that fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. U.S. GAAP also requires that a fair value measurement reflect the assumptions market participants would use in pricing an asset or liability based upon the best information available.

 

U.S. GAAP establishes a three-level valuation hierarchy for disclosure of fair value measurements. The valuation hierarchy categorizes assets and liabilities at fair value into one of three different levels depending on the observability of the inputs employed in the measurement. The three levels are defined as follows:

 

  ● Level 1 – inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.

 

  ● Level 2 – inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs are observable for the asset or liability, or unobservable but corroborated by market data, for substantially the full term of the financial instrument.

 

  ● Level 3 – inputs to the valuation methodology are unobservable and significant to the fair value measurement.

 

A financial instrument’s categorization within the valuation hierarchy is based upon the lowest level of the input that is significant to the fair value measurement. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability.

 

F-11

 

6. Other Comprehensive Loss

 

For the year ended December 31, 2021 the Company incurred other comprehensive gain of approximately $6 million from foreign currency translation adjustments, including the reclassification of prior amounts into then-current year results.

 

7. Major Customers

 

For the year ended December 31, 2022, the Company had two customers that accounted for approximately 36% and 35% of consolidated net sales from continuing operations. For the year ended December 31, 2021, those same two customers accounted for approximately 57% and 19% of consolidated net sales. At December 31, 2022 and December 31, 2021, the outstanding accounts receivable balance due from these customers were $0.1 million and $1.3 million, respectively.

 

8. Inventories

 

Inventories are stated at the lower of cost or net realizable value. Cost is determined using standard costs which approximate costing determined on a first-in, first out basis. Standard costs are reviewed and adjusted periodically and at year end based on actual direct and indirect production costs. On a periodic basis, the Company reviews its inventory for estimated obsolescence or unmarketable items, primarily by reviewing future demand requirements and shelf life of the product.

 

Inventories of continuing operations are comprised of the following:

 

  

December 31,

2022

  

December 31,

2021

 
Raw materials  $1,457,000   $1,249,000 
Work in Process   2,513,000    2,492,000 
Finished Goods   4,355,000    4,135,000 
           
Total inventories  $8,325,000   $7,876,000 

 

9. Notes Payable

 

Long term debt consists of:

 

   2022   2021 
   December 31, 
   2022   2021 
Subordinated notes (officer) due December 2023  $1,267,000   $1,193,000 
Other Note   172,000    167,000 
Term Loan (2022 and 2021 are net of deferred finance costs of $0.1 million and $0.2 million, respectively)   543,000    559,000 
Line of Credit   2,878,000    5,003,000 
           
Total long-term debt   4,860,000    6,922,000 
           
Less current portion   (3,166,000)   (6,922,000)
Total Long-term debt, net of current portion  $1,694,000   $- 

 

F-12

 

Line of Credit and Term Loan

 

During December 2017, we entered in new financing agreements with PNC Bank, National Association (“PNC”). The financing agreements with PNC (the “PNC Agreements”) included a $6 million term loan and an $18 million revolving credit facility (the “Revolving Credit Facility”), with a credit facility termination date of December 2022. Available credit under the Revolving Credit facility was determined by eligible receivables and inventory at CTI Industries (U.S.) and Flexo Universal (Mexico). We notified PNC of our failure to meet certain financial covenants and conditions during multiple occasions between 2018 and 2021, resulting in amendments to the loan documents, and in some cases forbearance agreements, along with related fees, penalties and conditions.

 

On September 30, 2021 (the “Closing Date”), the Company entered into a loan and security agreement (the “Agreement”) with Line Financial (the “Lender”), which provides for a senior secured financing consisting of a revolving credit facility (the “Revolving Credit Facility) in an aggregate principal amount of up to $6 million (the “Maximum Revolver Amount”) and term loan facility (the “Term Loan Facility”) in an aggregate principal amount of $731,250 (“Term Loan Amount” and, together with the Revolving Credit Facility, the “Senior Facilities”). Proceeds of loans borrowed under the Senior Facilities were used to repay all amounts outstanding under the Company’s PNC Agreements and for the Company’s working capital. The Senior Facilities are secured by substantially all assets of the Company.

 

Interest on the Senior Facilities shall be the prime rate published from time to time published in the Wall Street Journal (7.5% as of December 16, 2022), plus 1.95% per annum, accruing daily and payable monthly. Interest shall be calculated on the basis of a 360-day year for the actual number of days elapsed. The Term Loan Facility shall be repaid by the Company to Lender in 48 equal monthly installments of principal and interest, each in the amount of $15,234, commencing on November 1, 2021, and continuing on the first day of each month thereafter until the Term Loan Maturity Date (as defined in the Agreement). Also, the Company would pay the Lender collateral monitoring fees of 4.62% of the eligible accounts receivable, inventory, and equipment supporting the Revolving Credit Facility and the Term Loan. During August 2022 the terms above were modified to reduce the collateral monitoring fee to 2.77%, and added a provision that barred the Company from repaying the facility prior to September 2023. In addition, the Company paid the Lender a loan fee of 1.25% of the Maximum Revolver Amount and the Term Loan Amount upon the execution of the Agreement.

 

The Senior Facilities mature on September 30, 2023 and shall automatically be extended for successive periods of one year each, unless the Company or the Lender gives the other party written notice of termination not less than 90 days prior to the end of such term or renewal term, as applicable. If the Senior Facilities are renewed, the Company shall pay the Lender a renewal fee of 1.25% of the Maximum Revolver Amount and the Term Loan Amount upon each renewal on the anniversary of the Closing Date. The Company has the option to prepay the Term Loan Facility (together with all accrued but unpaid interest and a Term Loan Prepayment Fee (as defined the Agreement) in whole, but not in part, upon not less than 60 days prior written notice to the Lender.

 

The Senior Facilities require that the Company shall, commencing December 31, 2021, maintain Tangible Net Worth of at least $4,000,000 or greater (“Minimum Tangible Net Worth”). Minimum Tangible Net Worth may be adjusted downward by the Lender, from time to time, in its sole and absolute discretion, based on the effect of non-cash charges and other factors on the calculation of Tangible Net Worth. Other debt subordinated to Lender is not considered as a reduction of this calculation. The Company believes it was in compliance with this covenant as of December 31, 2022 and 2021, respectively.

 

The Senior Facilities contain certain affirmative and negative covenants that limit the ability of the Company, among other things and subject to certain significant exceptions, to incur debt or liens, make investments, enter into certain mergers, consolidations, and acquisitions, pay dividends and make other restricted payments, or make capital expenditures exceeding $1,000,000 in the aggregate in any fiscal year.

 

As of December 31, 2022 and 2021, the term loan balance amounted to $0.5 million and $0.6 million, respectively, which consisted of the principal and interest payable balance and deferred financing costs. The balance of the Revolving Line of Credit as of December 31, 2022 and 2021 amounted to $2.9 million and $5.0 million, respectively.

 

Subordniated (Officer) Note

 

As of January 1, 2019, the Company had a note payable to John H. Schwan, former Director and former Chairman of the Board, for $1.6 million, including accrued interest. This loan accrues interest, is due December 31, 2023, and is subordinate to the Senior Facilities. During January 2019, Mr. Schwan converted $600,000 of the note into approximately 181,000 shares of our common stock at the then market rate of $3.32 per share. As a result of the conversion, the loan balance decreased to $1.0 million. The loan and interest payable to Mr. Schwan amounted to $1.3 million and $1.2 million as of December 31, 2022 and 2021, respectively. No payments were made to Mr. Schwan during 2022 or 2021. Interest expense related to this loan amounted to $18,000 and $17,000 for the three months ended December 31, 2022 and 2021, respectively, and $74,000 and $70,000 for the twelve months ended December 31, 2022 and 2021, respectively.

 

Other Note

 

As of December 31, 2021, the Company had a note payable to Alex Feng  for $166,667. This loan accrues interest at 3% and is subordinate to the Senior Facilities. The subordination agreement signed September 30, 2021 changes the term of the maturity date from November 2023 to March 2024 and payment date starting April 2022.

 

F-13

 

10. Income Taxes

 

Tax Reform act of 2017

 

On December 22, 2017, the Tax Cuts and Jobs Act was enacted into law and introduced significant changes to U.S. tax law. The Company reflected the impacts of changes in tax law to the financial statements including the federal income tax rate reduction from 35% to 21%; the new limitations on the tax deductibility of interest expense; the acceleration of business asset expensing; the repeal of the alternative minimum tax (“AMT”); the limitation on the use of net operating losses generated in future years; and the Global Intangible Low Taxed Income regime. On March 27, 2020, the CARES Act was enacted into law and introduced changes to U.S. tax law including revised limitations on the tax deductibility of interest expense and the limitation on the use of net operating losses.

 

Due to an ownership change in the first quarter of 2020, the future utilization of certain post-change income tax attributes of Yunghong CTI Ltd , including net operating loss carryovers, are anticipated to be limited for U.S. income tax purposes.

 

The provision (benefit) for income taxes consists of the following:

 

           
   Year Ended December 31, 
   2022   2021 
Current:          
Federal  $-   $- 
State   -    - 
Foreign   -    - 
Total Current   -    - 
           
Deferred:          
Federal  $-   $- 
State   -    - 
Foreign   -    - 
Total Deferred   -    - 
Provision (Benefit) for income taxes   -    - 

 

Income tax provision (benefit) related to continuing operations differ from the amounts computed by applying the statutory income tax rate of 21% to pretax loss as follows (in thousands):

 

           
   Year Ended December 31, 
   2022   2021 
U.S. Federal provision (benefit)          
At Statutory Rate  $(120,000)  $(743,000)
State Taxes   25,000   (770,000)
Change in Valuation Allowance   50,000    1,792,000 
NOL Carryback Claim (CARES Act)   -    - 
Nondeductible Expenses   -    - 
Foreign Taxes   -    - 
Deconsolidation & Impairment   (32,000)   (623,000)
Other   77,000    344,000 
           
Total  $-   $- 

 

F-14

 

Deferred Tax Assets and Liabilities

 

Deferred income taxes reflect the net tax effects of loss and credit carryforwards and temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of our deferred tax assets for federal and state income taxes are as follows):

Schedule of Deferred Tax Assets and Liabilities

 

   2022   2021 
   Year Ended December 31, 
   2022   2021 
Deferred Tax Assets:          
Federal & State NOL Carryforward   3,241,000    2,696,000 
Foreign Tax Credit & Other Credits   307,000    308,000 
Capitalized R&D   55,000    - 
Reserves and Accruals   152,000    205,000 
Capital Loss Carryforward   2,378,000    2,360,000 
Unicap 263A Adjustment   233,000    282,000 
Other DTA   (91,000)   (90,000)
Foreign NOL Carryforward   2,000    2,000 
Deferred Interest Expense   1,704,000    1,578,000 
ERC Wage Disallowance   -    313,000 
Deconsolidation & Impairment   -    415,000 
Total Gross DTA   7,982,000    8,069,000 
Less: Val. Allowance   (8,159,000)   (8,115,000)
Total Deferred Tax Assets   (177,000)   (46,000)
           
Deferred Tax Liabilities:          
Fixed Assets & Intangibles   233,000    158,000 
Section 481(a) Adjustment   (56,000)   (112,000)
Total Gross DTL   177,000    46,000 
Net Deferred Tax Assets   -    - 

 

Realization of our deferred tax assets is dependent upon future earnings, if any, the timing and amount of which are uncertain. Due to the lack of earnings history and in light of management’s comments regarding going concern for most of 2019 through December 31, 2022, a valuation allowance has been recorded to reduce the deferred tax assets to its net realizable value. The valuation allowance increased by $0.4 million and increased by $1.7 million during the years ended December 31, 2022 and December 31, 2021, respectively. The valuation allowance includes no benefit related to stock based compensation and exercises for the years ended December 31, 2022 and 2021, respectively, prior to the implementation of ASC 515 and 718, that will be credited to additional paid in capital when realized.

 

Net Operating Loss and Tax Credit Carryforwards

 

As of December 31, 2022, we had a net operating loss carryforward for federal income tax purposes of approximately $9.8 million, of which $0.2 million is subject to expiration beginning 2037. We had a total state net operating loss carryforward of approximately $12.5 million, with various expiration dates. Utlization of some of the federal and state net operating loss and credit carryforwards are subject to annual limitations due to the “change in ownership” provisions of the Internal Revenue Code of 1986 and similar state provisions. The annual limitations may result in the expiration of net operating losses and credits before utilization.

 

11. Related Party Transactions

 

Ms. Jana M. Schwan is the Company’s Chief Operating Officer. Her father, John H. Schwan, held several positions with the Company over many years, most recently as Chairman of the Board until June 2020. His brother is Gary Schwan, one of the owners of Schwan Incorporated, which provides building maintenance services to the Company. The Company made payments to Schwan Incorporated of approximately $1,000 and $13,000 during the years ended December 31, 2022 and 2021, respectively.

 

As discussed in Note 9, Mr. John H. Schwan was owed approximately $1.3 million and $1.2 million as of December 31, 2022 and 2021, respectively in a note from the Company.

 

F-15

 

12. Commitments

 

Operating Leases

 

We adopted ASC Topic 842 (Leases) on January 1, 2019 using the modified retrospective method. This standard requires us to record certain operating lease liabilities and corresponding right-of-use assets on our balance sheet. We elected the package of practical expedients available for expired or existing contracts, which allowed us to carryforward our historical assessments of whether contracts are (or contain) leases, as well as lease classification tests and treatment of initial direct costs. We also elected to not separate lease components from non-lease components for all fixed payments, and we exclude variable lease payments in the measurement of right-of-use assets and lease obligations.

 

Upon adoption of ASC 842 we recorded a $2.8 million increase in other assets, a $1.1 million increase in current liabilities, and a $1.7 million increase in non-current liabilities. We did not record any cumulative effect adjustments in opening retained earnings, and adoption of ASC 842 had no impact on cash flows from operating, investing, or financing activities.

 

We determine if an arrangement is a lease at inception. Most of our operating leases do not provide an implicit rate of interest so we use our incremental borrowing rate based on the information available at the commencement date to determine the present value of future payments. We lease various assets in the course of ordinary business including warehouses and manufacturing facilities, as well as vehicles and equipment used in our operations. Leases with an initial term of 12 months or less are not recorded on the balance sheet as we recognize lease expense for these leases on a straight-line basis over the lease term. The depreciable life of assets and related improvements are limited by the expected lease term, unless there is a reasonably certain expected transfer or title or purchase option. Some lease agreements include renewal options at our sole discretion. Any guaranteed residual value is included in our lease liability.

 

The table below describes our lease position as of December 31, 2022 and 2021:

 

           
Assets  As of
December 31,
2022		   As of
December 31,
2021		 
Operating lease right-of-use assets   4,805,000    4,031,000 
Accumulated amortization   (923,000)   (501,000)
Net lease assets   3,882,000    3,530,000 
           
Liabilities          
Current          
Operating   518,000    670,000 
Noncurrent          
Operating   3,364,000    2,860,000 
Total lease liabilities   3,882,000    3,530,000 
           
Weighted average remaining term (years) – operating leases   8    9 
           
Weighted average discount rate – operating leases   11.25%   11.25%

 

During the year ended December 31, 2022 and 2021, we recorded expenses related to

 

   2022   2021 
   Year ended December 31 
   2022   2021 
Operating right-of-use lease asset amortization   746,000    501,000 
           
Financing lease asset amortization   -    - 
Related interest expense   -    - 
           
Total expense during twelve months ended December 31   746,000    501,000 

 

The following table summarizes the maturities of our lease liabilities for all operating leases as of December 31, 2022

 

(in thousands)  12/31/2022 
     
2023   949 
2024 and thereafter   5,074 
Total lease payments   6,023 
less: Imputed interest   (2,141)
Present value of lease liabilities   3,882 

 

F-16

 

13. Convertible Redeemable Preferred Stock

 

Series A Convertible Preferred Stock

 

On January 3, 2020, the Company entered into a stock purchase agreement (as amended on February 24, 2020 and April 13, 2020 (the “LF Purchase Agreement”)), pursuant to which the Company agreed to issue and sell, and LF International Pte. Ltd., a Singapore private limited company (“LF International”), which is controlled by Company director, Chairman, President and Chief Executive Officer, Mr. Yubao Li, agreed to purchase, up to 500,000 shares of the Company’s newly created shares of Series A Preferred Stock (“Series A Preferred”), with each share of Series A Preferred initially convertible into ten shares of the Company’s common stock, at a purchase price of $10.00 per share, for aggregate gross proceeds of $5,000,000 (the “LF International Offering”). As permitted by the Purchase Agreement, the Company may, in its discretion issue up to an additional 200,000 shares of Series A Preferred for a purchase price of $10.00 per share (the “Additional Shares Offering,” and collectively with the LF International Offering, the “Offering”). Approximately $1 million of Series A Preferred has been sold, including to an investor which converted an account receivable of $478,000 owed to the investor by the Company in exchange for 48,200 shares of Series A Preferred. The Company completed several closings with LF International from January 2020 through June 2020. The majority of the funds received reduced our bank debt. We issued a total of 400,000 shares of common stock to LF International and, pursuant to the LF Purchase Agreement, changed our name from CTI Industries Corporation to Yunhong CTI Ltd. LF International has the right to name three directors to serve on our Board. They were Mr. Yubao Li, Ms. Wan Zhang and Ms. Yaping Zhang. Ms. Wan Zhang and Ms. Yaping Zhang retired from the Board in January 2022.

 

The issuance of the Series A Preferred generated a beneficial conversion feature (BCF), which arises when a debt or equity security is issued with an embedded conversion option that is beneficial to the investor or in the money at inception because the conversion option has an effective strike price that is less than the market price of the underlying stock at the commitment date. The fair value of the common stock into which the Series A Preferred was convertible exceeded the allocated purchase price fair value of the Series A Preferred Stock at the closing dates by approximately $2.5 million as of the closing dates. We recognized this BCF by allocating the intrinsic value of the conversion option, to additional paid-in capital, resulting in a discount on the Series A Preferred. As the Series A Preferred is immediately convertible, the Company accreted the discount on the date of issuance. The accretion was recognized as dividend equivalents.   Holders of the Series A Preferred will be entitled to receive quarterly dividends at the annual rate of 8% of the stated value ($10 per share). Such dividends may be paid in cash or in shares of common stock at the Company’s discretion. In the three and nine months ended September 30, 2022, the Company accrued $67,000 and $267,000 of these dividends in each period, respectively. On September 1, 2022, the investor converted Preferred Series A into 5 million shares of common stock and approximately 1.3 million shares of common stock representing accrued dividends. 

 

Series B Convertible Preferred Stock

 

In November 2020, we issued 170,000 shares of Series B Preferred for an aggregate purchase price of $1,500,000. The Series B Preferred have an initial stated value of $10.00 per share and liquidation preference over common stock. The Series B Preferred is convertible into shares of our common stock equal to the number of shares determined by dividing the sum of the stated value and any accrued and unpaid dividends by the conversion price of $1.00. The Series B Preferred accrues dividends at a rate of 8 percent per annum, payable at our election either in cash or shares of the Company’s common stock. Initially, the Series B Preferred, in whole or part, was redeemable at the option of the holder (but not mandatorily redeemable) at any time on or after November 30, 2021 for the stated value, plus any accrued and unpaid dividends and thus was classified as mezzanine equity and initially recognized at fair value of $1.5 million (the proceeds on the date of issuance). In March 2021, the terms of the Series B Preferred were modified to eliminate the ability of the holder to redeem the Series B Preferred. As the Series B Preferred is no longer redeemable, the Series B Preferred is not classified as mezzanine equity as of December 31, 2022 or December 31, 2021. As a result, the carrying value as of December 31, 2022 and 2021 amounted to $1,851,000 and $1,715,000, respectively. The December 31, 2022 balance consists of $1,500,000 original carrying value, $304,000 accrued dividends and $47,000 accretion. On February 1, 2023, the investor converted Preferred Series B into approximately 1.9 million shares of common stock.

 

Series C Convertible Preferred Stock

 

In January 2021 we entered into an agreement with a related party, LF International Pte. Ltd. which is controlled by Company director and Chairman, Mr. Yubao Li, to purchase shares of Series C Preferred stock. We issued 170,000 shares of Series C Preferred for an aggregate purchase price of $1,500,000. The Series C Preferred have an initial stated value of $10.00 per share and liquidation preference over common stock. The Series C Preferred is convertible into shares of our common stock equal to the number of shares determined by dividing the sum of the stated value and any accrued and unpaid dividends by the conversion price of $1.00. The Series C Preferred accrues dividends at a rate of 8 percent per annum, payable at our election either in cash or shares of the Company’s common stock. The issuance of the Series C Preferred generated a beneficial conversion feature (BCF), which arises when a debt or equity security is issued with an embedded conversion option that is beneficial to the investor or in the money at inception because the conversion option has an effective strike price that is less than the market price of the underlying stock at the commitment date. The fair value of the common stock into which the Series C Preferred was convertible exceeded the allocated purchase price of the Series C Preferred at the closing dates by greater than the allocated purchase price. Therefore, the BCF was the purchase price of the Series C Preferred ($1.5 million) and was allocated to Additional Paid-in Capital, resulting in a discount on the Series C Preferred Stock. As the Series C Preferred Stock is immediately convertible, the Company accreted the discount on the date of issuance. The accretion to the carrying value of the Series C Preferred is treated as a deemed dividend, recorded as a charge to Additional Paid in Capital and deducted in computing earnings per share. The carrying value as of August 30, 2022 and December 31, 2021 amounted to $1,698,000 and $1,630,000, respectively. On September 1, 2022, the investor converted Series C into 1.7 million shares of common stock and accrued dividends in the amount of approximately 0.3 million shares of common stock.

 

F-17

 

Series D Convertible Preferred Stock

 

In June 2021, the Company received $1.5 million from an unrelated third party as an advance on a proposed sale of Series D Redeemable Convertible Preferred Stock. As of September 30, 2021, the Company was in the process of negotiating and finalizing the terms of the arrangement. As the agreement was not finalized as of September 30, 2021, the $1.5 million advance was classified as Advance from Investor within liabilities on the balance sheet at that time. As of December 31, 2021, the terms had been finalized, the investment was classified as equity, similar to the prior Convertible Preferred issuances, above. The issuance of the Series D Preferred generated a beneficial conversion feature (BCF), which arises when a debt or equity security is issued with an embedded conversion option that is beneficial to the investor or in the money at inception because the conversion option has an effective strike price that is less than the market price of the underlying stock at the commitment date. The fair value of the common stock into which the Series D Preferred was convertible exceeded the allocated purchase price fair value of the Series D Preferred Stock at the closing dates by approximately $0.3 million as of the closing dates. We recognized this BCF by allocating the intrinsic value of the conversion option, to additional paid-in capital, resulting in a discount on the Series D Preferred. As the Series D Preferred is immediately convertible, the Company accreted the discount on the date of issuance. The accretion was recognized as dividend equivalents. Holders of the Series D Preferred will be entitled to receive quarterly dividends at the annual rate of 8% of the stated value ($10 per share). Such dividends may be paid in cash or in shares of common stock at the Company’s discretion. In addition, 128,000 warrants to purchase the Company’s common stock were issued with respect to this transaction. These warrants are exercisable until December 1, 2024, at the lower of $1.75 per share or 85% of the variable price based on the ten day volume weighted average price (“VWAP”) of the Company’s common stock. The value of these warrants was determined to be $230,000 and recorded as an allocation of paid in capital associated with this transaction. The carrying value as of September 1, 2022 and December 31, 2021 amounted to $1,580,000 and $1,512,000, respectively. On September 1, 2022, the investor converted Preferred Series D into 1.7 million shares of common stock and received accrued dividends of approximately 0.1 million shares of common stock.

 

 Schedule of Preferred Stock

Preferred Stock

Rollforward

  

Balance as of

December 31, 2021

    

Accrued Deemed

Dividends

    

Balance as of

December 31, 2022

  
Series B     1,715,000       102,000       1,851,000  

 

Warrants

 

A summary of the Company’s stock warrant activity is as follows:

 

 

   Shares under
Option		   Weighted
Average
Exercise
Price		 
Balance at December 31, 2021   128,000   $1.75 
Granted   -    - 
Cancelled/Expired   -    - 
Exercised/Issued   -    - 
Outstanding at December 31, 2022   128,000    1.75 
           
Exercisable at December 31, 2022   128,000   $1.75 

 

As of December 31, 2022 and December 31, 2021 the Company reserved the following shares of its common stock for the exercise of warrants, and preferred stock:

 

Series B Preferred Stock   1,700,000 
2021 Warrants   128,572 
Shares reserved as of December 31, 2022 and December 31, 2021   1,828,572 

 

14. Other Stockholders’ Equity

 

Common Stock

 

During 2020, 400,000 shares of our common stock were issued to LF related to the acceleration of closings in our Series A Offering, and an additional 200,000 shares were issued to Garden State Securities in its representation of the Company in the Series A Offering.

 

F-18

 

Restricted Stock

 

In 2020, 15,000 shares of restricted stock vested to Mr. Hyland, former Chief Executive Officer, pursuant to the terms of the grant related to his employment with the Company. There were no other shares of restricted stock outstanding during 2020 or 2021. During 2022, 250,000 shares of restricted stock were granted to the incoming Chief Executive Officer pursuant to an employment agreement. 25,000 of those shares are to vest immediately and the remaining shares are schedule to vest upon the achievement of certain performance conditions. Each of three independent directors received grants of 5,000 shares that were fully vested as of December 31, 2022. Additionally, the Chief Operating Officer was granted 100,000 shares, 20,000 of which vested over 12 months while the remaining 80,000 had the same performance conditions as the Chief Executive Officer. During 2022, the performance condition related to 56,250 shares for the Chief Executive Officer and 20,000 shares for the Chief Operating Officer was met, and these shares vested. As of December 31, 2022, performance conditions related to 168,750 shares for the Chief Executive Officer and 60,000 shares for the Chief Operating Officer remain unvested.

 

Stock Options

 

The Compensation Committee (“Committee”) administers the Company’s stock-based plans. The exercise price of the stock options shall be fixed by the Committee at whatever price the Committee may determine in good faith. Unless the Committee determines otherwise, options generally had a 4-year term with a 3-year vesting schedule. Unless the Committee provides otherwise, options terminate upon the termination of a participant’s employment, except that the participant may exercise an option to the extent it was exercisable on the date of termination and for a period of time after termination.

 

In 2009, the shareholders of the Corporation approved, a 2009 Stock Incentive Plan (“2009 Plan”). The 2009 Plan and subsequent awards categorized as inducement of employment authorized the issuance of up to 510,000 shares of stock or options to purchase stock of the Company (including cancelled shares reissued under the plan.)

 

On June 8, 2018, our shareholders approved the 2018 Stock Incentive Plan (“2018 Plan”). The 2018 Plan authorized the issuance of up to 300,000 shares of our common stock in the form of equity-based awards. Because no registration on Form S-8 was filed for these additional shares within 12 months of approval by our shareholders, those additional shares are not available for issuance in the normal course. On June 17, 2022, our shareholders approved of the issuance of 500,000 shares to this plan.

 

The Company, at the discretion of the board, may issue options in excess of the total available, if options related to that stock plan are cancelled. In some cases, not all shares that are available to a stock plan are issued, as the Company is unable to issue options to a previous plan when a new plan is in place.

 

The Company recognized share based compensation expense of approximately $160,000 and $0 in 2022 and 2021. As of December 31, 2022 and 2021, respectively, there was no unrecognized compensation expense related to non-vested stock option grants. There were approximately 228,000 performance-based grants for which the underlying performance threshold had not been met as of December 31, 2022.

 

Warrants

 

In connection with the Series A Offering, in 2020 the Company issued 792,660 warrants to purchase 792,660 shares of the Company’s common stock for $1 per share. During 2020, 597,500 warrants were exercised in cash-less exchange for 391,308 shares of the Company’s common stock. In January and February 2021, the remaining 195,160 warrants were exercised in a cash-less exchange for 103,104 shares of the Company’s common stock.

 

The Series D Offering also included warrants to purchase up to 128,572 shares of the Company’s common stock at an exercise price of the lower of $1.75 per share or 85% of the lowest daily volume-weighted average price of the Common Stock during the 10 trading days prior to the date of exercise. If unexercised, these warrants expire December 1, 2024.

 

The Company has applied the Black-Scholes model to value stock-based awards. That model incorporates various assumptions in the valuation of stock-based awards relating to the risk-free rate of interest to be applied, the estimated dividend yield and expected volatility of the Company’s Common Stock. The risk-free rate of interest is the U.S. Treasury yield curve for periods within the expected term of the option at the time of grant. The expected volatility is based on historical volatility of the Company’s Common Stock.

 

The valuation assumptions we have applied to determine the value of warrants granted in 2021 and 2020 were as follows:

 

Historical stock price volatility: The Company used the weekly closing price to calculate historical annual volatility.

 

Risk-free interest rate: The Company bases the risk-free interest rate on the rate payable on US treasury securities with a similar maturity in effect at the time of the grant, which was 3.80% and 0.30%, during 2022 and 2021, respectively.

 

Expected life: The expected life of the warrants represents the period of time warrants were expected to be outstanding. The Company used an expected life of 5 years for all warrants granted during 2022 and 2021.

 

Dividend yield: The estimate for dividend yield is 0%, as the Company did not issue dividends during 2022 or 2021 and does not expect to do so in the foreseeable future.

 

Estimated forfeitures: When estimating forfeitures, the Company considers historical terminations as well as anticipated retirements.

 

F-19

 

A summary of the Company’s stock options, warrants and related information, is as follows:

 

   Options   Weighted
Average
Exercise
Price		   Warrants   Weighted
Average
Exercise
Price		 
Balance at January 1, 2021   -   $      -    195,160    1.00 
Granted   -         128,572    1.75 
Cancelled/Expired   -                
Exercised/Issued   -         (195,160)   1.00 
Balance at December 31, 2021   -         128,572   $1.75 
Granted   -         -      
Cancelled/Expired   -                
Exercised/Issued             -      
Balance at December 31, 2022   -         128,572   $1.75 
                     
Exercisable at December 31, 2022             128,572   $1.75 

 

As there are no active stock options, there is no aggregate intrinsic value (the difference between the closing price of the Company’s common stock as of December 31, 2022 and 2021, respectively, and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all the holders exercised their options on December 31, 2022 and 2021, respectively. The warrants have an intrinsic value of $230,000 and $230,000 as of December 31, 2022 and 2021, respectively.

 

As of December 31, 2022 and 2021, the Company reserved the following shares of its common stock for the exercise of warrants, and preferred stock:

2021 Warrants   128,572 
Series B Preferred Stock   1,700,000 
Shares reserved as of December 31, 2022   1,828,572 

 

F-20

 

15. Earnings Per Share

 

Basic earnings per share is computed by dividing net loss attributable to Yunhong CTI Ltd. Common shareholders by the weighted average number of shares of common stock outstanding during each period.

 

Diluted earnings per share is computed by dividing net loss attributable to Yunhong CTI Ltd. Common shareholders by the weighted average number of shares of common stock and equivalents (stock options and warrants), unless anti-dilutive, during each period.

 

         
Consolidated earnings per share  2022   2021 
Loss from continuing operations  $(1,467,000)  $(7,728,000)
Loss attributable to noncontrolling interest   -    (718,000)
Deemed dividends on preferred stock and amortization of beneficial conversion feature   (584,000)   (3,573,000)
Loss from continuing operations attributable to Yunhong CTI Ltd common shareholders  $(2,051,000)  $(10,323,000)
(Gain)/loss attributable to noncontrolling interest   -    174,000 
Loss from discontinued operations attributable to Yunhong CTI Ltd common shareholders  $-   $(11,845,000)
           
Basic and Diluted loss per common share:          
Continuing operations  $(0.22)  $(2.04)
Discontinued operations   -    0.03 
Total  $(0.22)  $(2.01)
           
Basic and Diluted weighted average number of shares and equivalent shares of common stock outstanding   9,301,888    5,878,887 

 

16. Product and Geographic Segment Data

 

The Company’s operations consist of a single business segment which designs, manufactures, and distributes film products.

 

F-21

 

The following table provides a breakdown of product net sales from operations in each of the years indicated (in thousands):

 

   Twelve Months Ended 
   December 31, 2022   December 31, 2021 
   $   % of   $   % of 
Product Category  (000) Omitted   Net Sales   (000) Omitted   Net Sales 
                 
Foil Balloons   10,858,000    60%   18,235,000    76%
                     
Film Products   2,036,000    11%   2,386,000    10%
                     
Other   5,154,000    29%   3,463,666    14%
                     
Total   18,048,000    100%   24,085,666    100%

 

17. Contingencies

 

In the ordinary conduct of our business, we are from time to time subject to lawsuits, investigations and claims, including environmental claims and employee-related matters. Although we cannot predict with certainty the ultimate resolution of lawsuits, investigations and claims asserted against us, including civil penalties or other enforcement actions, we do not believe that any currently pending legal proceeding or proceedings to which we are a party will have a material adverse effect on our business, financial condition or results of operations.

 

18. Legal Proceedings

 

The Company may be party to certain lawsuits or claims arising in the normal course of business. The ultimate outcome of these matters is unknown but, in the opinion of management, we do not believe any of these proceedings will have, individually or in the aggregate, a material adverse effect upon our financial condition, cash flows or future results of operation.

 

F-22

 

19. Discontinued Operations

 

In July 2019 management and the Board engaged in a review of CTI Balloons and CTI Europe and determined that they are not accretive to the Company overall, add complexity to the Company’s structure and utilize resources. Therefore, as of July 19, 2019, the board authorized management to divest of CTI Balloons and CTI Europe. These actions were taken to focus our resources and efforts on our core business activities, particularly foil balloons and ancillary products based in North America. The Company determined that these entities met the held-for-sale and discontinued operations accounting criteria. Accordingly, the Company reported the results of these operations as discontinued operations in the Consolidated Statements of Comprehensive Income and presented the related assets and liabilities as held-for-sale in the Consolidated Balance Sheets. These changes were applied for all periods presented. The Company divested its CTI Balloons (United Kingdom) subsidiary in the fourth quarter 2019 and CTI Europe (Germany) subsidiary in the first half of 2021.

 

In connection with management’s intentions to simplify these operations and organizational structure, we identified write-offs of $1.75 million for the year ended December 31, 2019, respectively, related to CTI Europe, and CTI Balloons. The charges for the year ended December 31, 2019 were comprised of the following: $1.0M inventory, $67,000 allowance for doubtful accounts; and $8,000 for other assets.

 

In October 2019, we determined that we would not renew our Trademark License Agreement with SC Johnson when it expired on December 31, 2019. Under this Agreement, we were licensed to manufacture and sell a line of vacuum sealing machines and pouches under the Ziploc® Brand Vacuum Sealer System. The terms of the Agreement included a run-off provision which allowed us to sell products under the Ziploc® trademark for 90 days after the end of the Agreement. Our exit of the Ziploc® product line is considered a strategic shift and will have a major effect on our operations and financial results on a go forward basis therefore, this product line has been presented as discontinued operations and was abandoned as of March 31, 2020. The Ziploc® product line recorded losses from discontinued operations, net of taxes of ($2,024,851) for the year ended December 31, 2020. The Ziploc® product line recorded income from discontinued operations, net of taxes of $1,111,452 for the year ended December 31, 2019.

 

In October 2021, the Company sold its interest in Flexo Universal (its subsidiary in Mexico that manufactured latex balloons). This transaction was recorded during the fourth quarter of 2021. The Company recorded an expense of approximately $10 million associated with this transaction, as well as the reversal of previously recognized Other Comprehensive Income charges of approximately $6 million, for the year ended December 31, 2021. The Company received an aggregate of $245,000 from the sale date until December 31, 2021, part of the $500,000 it received in consideration of the sale As of December 31, 2021, the Company had a note receivable associated with the transaction of $255,000, which was subsequently collected over the course of 2022.

 

F-23

 

20. Subsequent Events

 

During May 2022 the Company received a notice of deficiency from the NASDAQ related to a failure to maintain a $1 bid price during a 30 day period. The Company had to achieve a $1 bid price for no fewer than ten (10) consecutive trading days during a 180 day grace period in order to regain compliance. During November, 2022, the Company had not regained compliance with the minimum bid price requirement which caused the NASDAQ to send the Company a delisting letter, subject to appeal. The Company filed a timely appeal, which was heard by a Hearing Panel on January 5, 2023. Consistent with the outcome of that Hearing, and in light of the recovery in the Company’s bid price, on January 19, 2023, the NASDAQ informed the Company that it had regained compliance with this standard.

 

During January 2023, approximately $0.8 million of our ERTC claims were processed and paid by the United States Government. We forwarded those receipts to the third party factoring entity, and recognized approximately $0.6 million of related deferred income.

 

During February 2023, the investor of Series B preferred converted into approximately 1.9 million shares of common stock. After that event, we no longer have any outstanding preferred stock.

 

F-24
Yunhong CTI (NASDAQ:CTIB)
Historical Stock Chart
From Mar 2025 to Apr 2025 Click Here for more Yunhong CTI Charts.
Yunhong CTI (NASDAQ:CTIB)
Historical Stock Chart
From Apr 2024 to Apr 2025 Click Here for more Yunhong CTI Charts.